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Abstract 
Background: The provision of glucose (Glu) is beneficial during ischaemia (Opie, 
1970). Part of Glu protection may be due to Glu oxidation, specifically the Krebs Cycle 
and oxidative phosphorylation (Lopaschuk, 1998). Therefore, 30 mM acetate (Ac) may 
hypothetically provide protection similar to 10 mM Glu providing that there is residual 
oxygen available to allow functioning of the Krebs Cycle and oxidative phosphorylation. 
Aim: The aim of this study was to establish an optimal Ac concentration at which the 
consequences of ischaemia were minimal, to determine whether the protective effects of 
Glu and. Ac is oxygen dependent, and to investigate whether equi-carbon concentrations 
of Ac and Giu would offer similar protection during low flow ischaemia. Materials and 
Methods: Isolated rat hearts (n = 6-8) were perfused (Langendorff, 95% 02, 5% CO2) 
with 5 mM Ac for 30 minutes, followed by 2 mlImin low flow ischaemia with 1 rnM or 5 
mM or 10 mM or 30 mM Ac or 10 mM Glu. Additional hearts were subjected to anoxia 
during the same period. All hearts were reperfused for 30 minutes under the pre-
ischaemic conditions. We measured the time to the onset of ischaemic contracture 
(TOIC), the percentage recovery of left ventricular developed pressure (L VDP), and 
tissue ATP, creatine phosphate, lactate, glycogen and cAMP content. Results: 5 mM 
and 10 mM Ac perfused hearts yielded optimal yet similar protection against the 
consequences of ischaemia. In addition, Ac (5 mM) and Glu (10 mM) treated hearts 
performed equally poorly in the absence of oxygen. This implies that the beneficial 
effects conferred by Glu is oxygen dependent, due possibly to the activity of the Krebs 
Cycle and oxidative phosphorylation. An equi-carbon concentration of Ac (30 mM) 
could not offer protection analogous to 10 mM Glu during oxygenated, low flow 
ischaemic conditions. Instead, 10 mM Glu provided optimal protection against 
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ischaemia while 30 mM Ac was associated with accelerated TOIC, reduced ATP and 
glycogen levels, elevated lactate and· cAMP levels, and weakened function upon 
reperfusion. Conclusion: Glu provided maximal protection against the consequences of 
low flow ischaemia. However, this protection was dependent on the availability of 
oxygen, suggesting that oxidative phosphorylation and Krebs Cycle activity may 
contribute more to the protective effects of a particular substrate than previously 
anticipated. 
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Uittreksel 
Agtergrond: Voorsiening van glukose (GIu) gedurende iskemie is voordelig (Opie, 
1970). Giu beskerming mag gedeeitelik te danke wees aan Giu oksidasie, spesifiek 
oksidatiewe fosforilering en die Krebs siklus (Lopaschuk, 1998). Dus mag 30 mM 
asetaat (Ac) beskerming soortgeIyk aan die van 10 mM Giu verleen, indien claar genoeg 
suurstofbeskikbaar is om funksionering van die Krebs Siklus en oksidatiewe fosforilering 
toe te Iaat. Doel: Die doel van hierdie studie was om 'n optimale Ac ko08entrasie vas te 
stel waar die gevolge van iskemie minimaal is, om te bepaal of die beskermingseffekte 
van Glu en Ac suurstof athanklik is, en om te ondersoek of ewe-kooistotkonsentrasies 
van Giu en Ac soortgeIyke beskerming gedurende lae vioei iskemie sal bied. Metodes: 
Geisoleerde rotharte (n = 6-8) is vir 30 minute met 5 mM Ac geperfuseer (Langendorff, 
95 % O2, 5 % CO2), gevoig deur 2 mVmin lae vloei iskemie met 6f ImM, 5 mM, 10 mM, 
of 30 mM Ac, 6f 10 mM Glu. Addisionele harte is tydens dieselfde periode aan anoksie 
blootgestel. AIle harte is vir 30 minute geherperfuseer onder die pre-iskemiese 
toestande. 008 het die tydsduur tot die begin van iskemiese kontraksie (TalC), die 
persentasie wat die linkerventrikulere ontwikkeide druk herstel (L VDP), en die weefsel 
ATP, kreatienfosfaat, Iaktaat, glikogeen en cAMP inhoud gemeet. Resultate: 5 mM en 
10 mM Ac het optimale, maar soortgelyke beskerming teen die gevolge van iskemie 
gebied. Ac (5 mM) en Glu (10 mM) behandelde harte het, in die afwesigheid van 
suurstof, ewe swak resultate getoon. Dit impliseer dat -die voordelige effekte verleen 
deur Glu suurstof afhanklik is en moontlik te danke is aan die aktiwiteit van die Krebs 
sikius en oksidatiewe fosforilering. Ewe-kooistotko08entrasies van Ac (30 mM) kon me 
soortgelyke beskerming as 10 mM Glu gedurende Iae vloei iskemie bied me. TerwyI Giu 
optimale beskerming teen iskemie gebied het, is Ac geassosieer met vervroegde TalC, 
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verlaagde ATP- en glikogeenvlakke, verhoogde Iaktaat- en cAMP-vlakke en swak: 
herstel van funksie tydens herperfusie. Gevolgtrekking: Glu het maksimale beskerming 
teen die gevolge van Iae vloei iskemie gebied. Die beskerming is egter suurstof afhanklik 
wat aandui dat oxidatiewe fosforilasie en die Krebs Siklus 'n groter bydra h~t tot die 
beskennende efi'ekte van 'n spesifieke substraat as wat voorheen verwag is. 
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Chapter 1 
INTRODUCTION 
1 
Since the introduction ofthe Glucose Hypothesis by Opie (1970), it is generally accepted 
that glucose has a protective effect on the ischaemic myocardium (Opie,1970; Apstein et 
aI., 1983;. Opie, 1989;. Owen et al., 1990; Oliver and Opie, 1994)). Possible beneficial 
actions of glucose include decreased incidence of ischaemic contracture (Owen et al., 
1990), reperfusion induced arrhythymias (Bernier and Hearse, 1988), and stunning 
(Ferrari et al., 1983). These protective effects may be mediated by increased production 
of glycolytic adenosine triphosphate (ATP) (Owen et al., 1990) which may, in turn, 
improve ion homeostasis through better control of the sarcoplasmic reticulum (SR) 
calcium pump, as well as other membrane pumps. If glycolytic ATP is responsible for 
the ben~ficial actions of glucose, glucose protection may be independent of oxygen 
availability since glycolysis does not require oxygen. The protection offered by glucose 
during low flow ischaemia should then be similar during anoxia. 
Alternatively, the protection conferred by glucose on the ischaemic heart may not be due 
solely to glycolysis (Lopaschuck, 1988). Under normoxic conditions, glucose yields 
more ATP through the Krebs Cycle and oxidative phosphorylation combined (34 ATP), 
than during glycolysis (2 ATP). Therefore, part of glucose protection may be due to 
increased ATP production by way of the fonner processes. If this is true, acetate, (a two 
carbon molecule) which is incorporated into the Krebs Cycle as acetyl coenzyme A 
(CoA), may offer protection similar to glucose (a six carbon molecule). This is provided 
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that the same number of carbon atoms are oxidised to carbon dioxide (C02) and there is 
sufficient oxygen to allow functioning of the Krebs Cycle and oxidative phosphorylation. 
Therefore, the aim of this study was: 
a) To establish an optimal acetate concentration which best protects the isolated rat 
heart against the consequences of low flow ischaemia 
b) To determine whether the availability of oxygen during low flow ischaemia influences. 
the protective effect of glucose and acetate 
c) To ascertain whether equi-carbon concentrations of acetate and glucose offers similar 
protection during subtotal ischaemia. 
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Chapter 2 
LITERATURE REVIEW 
2.1 Ischaemia 
The word ischaemia is derived from the Greek words, "'to'X,EtU" meaning "to restrain" 
and "atJ.1a" meaning "blood." There has however been much debate concerning the 
actual definition of myocardial ischaemia (Hearse, 1994). According to Opie (1987), it is 
simply defined as "a reversible oxygen deficit in the heart due to insufficient perfusion of 
the coronary arteries." Factors causing this myocardial oxygen imbalance include those 
which raise the oxygen demand such as tachycardia, wall stress, contractility, and 
metabolically driven "oxygen wastage". In contrast, coronary artery narrowing due to 
atheroma or spasm or both would decrease the oxygen supply (Opie, 1989). Ischaemic 
. heart disease (UID), coronary heart disease (CHD) and atherosclerosis all refer to clinical 
syndromes that may reduce blood flow to a region of the heart, thus disturbing the 
oxygen balance in the myocardium (Glass, 1977 p. 2; Katz, 1977 p. 419; Sharkey, 1979 
p. 180). Ifprolonged, ischaemia may develop into myocardial infarction, that is, necrosis 
(cell death) of the myocardium. 
Various experimental models exist for the investigation of myocardial ischaemia. These 
include regional ischaemia which is the result of coronary artery occlusion. In surgical 
ischaemia on the other hand, the entire heart is subjected to global ischaemia. During 
low flow ischaemia the coronary flow has simply been reduced, whereas in total 
ischaemia the coronary flow has been completely restricted. In practise however, 
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coronary flow is seldom totally arrested due to the presence of collateral flow in the 
ischaemic area. Growth of these collaterals is encouraged by the oxygen deficient heart 
in order to compensate for the oxygen imbalance. They occur on the epicardial surface, 
and are found in patients with IIID (Opie, 1987). The presence of collateral flow can 
prolong the time to necrosis. This, however depends on the degree of collateral blood 
flow present. The guinea pig, for example, has excellent collaterals, whereas rats have 
none (Opie, 1987). Therefore it is believed that extensive pre-existing collateral 
circulation can protect the ischaemic zone (Schaper, 1984). 
2.2 Myocardial metabolism 
The metabolism of the ischaemic myocardium is characterised by an ATP shortage as 
well as inhibition of glycolytic enzymes by the accumulation of lactate. This contributes 
further to the ATP deficiency (Opie,1988). Other detrimental changes include 
inadequate functioning of membrane pumps (Opie, 1990), potassium (K+) loss in the 
ischaemic zone (Opie, 1970; Weiss and Lamp, 1987), sarcolemmal damage, intracellular 
acidosis (Opie, 1975; Williamson et aI., 1976), accumulation of cyclic adenosine 
monophosphate (cAMP) (Wollenberger et aI., 1969), and deficient Ca ++ homeostasis 
(Henry et al., 1977). All of these factors contribute to ventricular arrhythmias and an 
eventual decline in myocardial contractility (i.e. pump failure). This may lead to acute 
heart failure (sudden death) where death occurs soon after coronary flow is reduced. 
Alternatively, the loss of functional myocardial tissue may initially be tolerated by the rest 
of the heart with death occurring after a prolonged period. This is termed as chronic 
heart failure (Katz, 1977 p.421). 
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The early consequences of ischaemia are potentially reversible as there is no detectable 
membrane damage associated with the initial K+ loss (Opie, 1987). Late ischaemic K+ 
loss is due to severe ATP depletion and inhibition of the sodium pump (Opie, 1989). 
Four main factors indicate irreversible ischaemic damage: 1) critical ATP loss 2) 
membrane damage 3) mechanical effects such as cell swelling and membrane rupture as 
a result of elevated osmotic pressure and finally 4) calcium overload (Opie, 1984). 
2.3 Energy Bearing Substrates 
Cardiac muscle utilises various metabolic fuels including fatty acids, glucose, lactate and 
ketone bodies (Opie, 1968; Neely et al., 1974). The rate of utilisation of these substrates 
depends on: 
a) the substrate concentration in the plasma 
b) the availability of alternate competitive substrates 
c) oxygen delivery to the myocardium 
d) mechanical activity of the heart and .. 
e) plasma levels of regulating hormones (Neely et aI., 1972). 
The myocardium depends on aerobic metabolism. The preferred substrate is fatty acids 
which fulfil 60%-90% of myocardial energy requirements (BraunwaId, 1992 p.1l83). 
These fatty acids are metabolised through B-oxidation and the Krebs/ Tricarboxylic Acid 
Cycle (Neelyet aI., 1972). Glycolysis and glucose oxidation are inhibited by high levels 
of fatty acids (Neely and Morgan, 1974) as well as the metabolism of ketone bodies and 
lactate (Opie, 1990). 
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During ischaemia there is a shift from aerobic to anaerobic metabolism (Oliver & Opie, 
1994). An oxygen deficiency prevents the oxidation of non-glucose substrates such as 
free fatty acids (FF A) and lactate. Glucose and glycogen now become the primary 
substrates while glycolysis and glucose oxidation are enhanced (Opie, 1990). Therefore 
the provision of appropriate energy-giving substrates, such as glucose, may protect 
against ischaemic injury (Oliver & Opie, 1994). 
2.3.1 Glucose 
As postulated by Opie (1970), glucose may be good for the survival of the ischaemic 
myocardium. Indices of protection include a reduction of reperfusion-induced 
arrhythmias (Bernier and Hearse, 1988), the attenuation of stunning (Ferrari et at, 
1983), and a decrease in the occurrence of ischaemic contracture (Owen et al., 1990). 
The mechanism underlying the protection conferred may be attributed to increased 
production of glycolytic ATP (Owen et al., 1990) and the resultant improvement in 
cytosolic Ca++ homeostasis (Opie, 1989), the inhibition of the ATP-sensitive K+ channels 
(KATP) (Weiss & Lamp, 1987), and lowering of cAMP levels in the ischaemic zone 
(Podzuweit et al., 1993); Furthermore, De Leiris et al. (1975) found increased enzyme 
release in hearts perfused with FF A in contrast to lower enzyme release in glucose 
perfused hearts. 
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Glucose 
Lactate + 
, /'" [GLYC~~YSIS I JJt:" 2 x coenzyme 2H 
pyruvate + 2 x coenzyme 2H 
FF AI Acetate ~ acetyl CoA 
-{> 1 2ATP I 
~ 
• I .. OXIDATIVE 
+ 
I KREBS CYCLE I 6 x coenzyme 2H 
2 x coenzyme 2H 
~' PHOSPHORYLATION 
~ 
~ 
1
2ATP I 
I 34ATP1 
Figure 2.1. Energy Producing Pathways. Complete oxidation of glucose to CO2 yields more AIP through oxidative phosphorylation than via 
glycolysis and the Krebs Cycle. Glucose oxidation through glycolysis yields 2 pyruvate, 2 ATP molecules and 2 coenzyme 2H. Pyruvate is 
converted to acetyl CoA and in the process another 2 coenzyme 2H is produced. Acetyl CoA is incorporated into the Krebs Cycle which then 
yields 2 ATP and 8 coenzyme 2H. Coenzyme 2H renders a total of34 ATP via oxidative phosphorylation. Acetate and FFA are introduced into 
this system as acetyl CoA. 
7 
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Normally, fatty acids are preferentially oxidised in the perfused rat heart (Shipp et al., 
1961). However, an oxygen deficiency prevents oxidation of these non-glucose 
substrates. Instead glucose uptake and glycolysis is enhanced (Opie, 1990) and glucose 
becomes the main source of energy. 
To maXlITllSe glucose uptake into the cardiocytes there must be adequate glucose 
delivery by the coronary blood flow and efficient transport of glucose from the blood to 
the interstitial space and finally into the cytosol (Achs and Garfinkel, 1977). Anoxia, 
where the oxygen tension is reduced, encourages glucose transport into the cell (Morgan 
et al., 1961). Similarly, moderate ischaemia, during which oxygen deprivation is due to 
limited coronary flow, also enhances glucose uptake (Rovetto et al., 1973). During 
severe ischaemia, where the coronary flow is drastically decreased, glucose uptake is 
reduced since its delivery to the myocardium is restricted (Achs and Garfinkel, 1977; 
Rovetto et al., 1973). Besides the coronary flow rate, (1.- and B-adrenergic receptors 
may also playa role in the control of glucose uptake through a Ca++ dependent control 
mechanism (Clark and Patten, 1984). 
While anoxia accelerates glucose transport, the rate of anaerobic glycolysis is enhanced 
by reduced inhibition of glycolytic enzymes. Free fatty acids and high energy phosphate 
compounds within the cell are responsible for this enzymatic inhibition (Opie, 1975). In 
moderate ischaemia, the majority of glucose enters the Krebs Cycle to produce energy 
via oxidative metabolism. Severe ischaemia limits flux through the Krebs Cycle and 
lactic acid accumulates within the myocardium (Rovetto et al., 1973). Together with 
protons, lactate inhibits glycolytic enzymes such as phosphofructokinase (PFK), 
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hexokinase (HK), phosphorylase kinase C, and glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH) (Figure 2.2) (Neely et ai., 1975). Thus during ischaemia, 
glycolytic flux is regulated by both the rate of glucose delivery and the severity of 
enzymatic inhibition. As the coronary flow is reduced, the influence of metabolic 
inhibition becomes increasingly important with metabolite accumulation limiting 
glycolytic flux at zero coronary flow (King et ai., 1995). This may explain why 
glycolytic flux is enhanced during mild ischaemia, and inhibited during severe ischaemia 
(Opie, 1990). 
Ischaemic myocardial metabolism may be improved by the promotion of glycolytic flux 
(Opie, 1989). Glycolysis can be enhanced by administration of glucose, insulin and 
potassium (GIK) (Broderick et ai., 1992). The administration of insulin accelerates 
glucose uptake (Morgan et ai., 1961; Van Rooyen et ai., 1998), while the provision of 
glucose increases the anaerobic glycolysis rate, lowers circulating FF A levels (Grayson 
and Irvine, 1968), and alters the extracellular volume (Opie, 1970). However, while 
glucose uptake and enzymatic regulation serve to influence glycolysis, the actual rate of 
ATP production may determine the degree of protection offered by glucose. 
Inhibition of glycolytic flux decreases the amount of ATP available which is required to 
control ion gradients (Opie, 1988). The uptake of Ca++ into the SR occurs by means of 
an ATP-dependent pump. Glycolytic ATP maintains this pump and when glycolysis is 
suppressed, Ca ++ may accumulate intracelluiarly leading to the development of ischaemic 
contracture, a form of ischaemic injury (Opie, 1987). Therefore glycolysis has a 
protective effect in the ischaemic and reperfusion period via better control of Ca ++ 
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homeostasis (Owen et aI., 1990). Glycolysis may, through the production of ATP, also 
playa role in the movement ofK+ across the cell membrane. ATP is required to prevent 
opening of the ATP-sensitive potassium (KATP) channels and ensure functioning of the 
Na+/K+ ATPase. Inhibition of glycolysis and ATP synthesis may lead to K+ loss. Weiss 
and Lamp (1987) showed similar findings when glycolysis was limited by the absence of 
glucose in the perfusate. They found a marked K+ loss from the cell as a result of 
reduced inhibition of the ATP-sensitive K+ channels when glucose was replaced by 
pyruvate or acetate as myocardial substrates. 
Despite evidence for a protective role of glucose, the effect of glycogen during ischaemia 
is controversial (Neely and Grotyohann 1984; Goodwin and Taegtmeyer, 1994). 
Glycogenolysis is both a source of glycolytic ATP as well as lactate and protons. 
Glycolytic ATP maintains ion gradients (Opie, 1988), while lactate and protons 
contribute to ischaemic injury by inhibiting glycolysis and inducing acidosis (Neely et aI., 
1973). Thus the effects of glycogen during ischaemia may depend on whether its 
beneficial qualities outweigh the detrimental consequences (Cross et aI., 1996). Using a 
total, global ischaemic model, Neely and co-workers (1984) found that high pre-
.~ 
ischaemic glycogen levels had a deleterious effect on functional recovery. However this 
may have been due to reduced washout of lactate and protons which then accumulate 
and inhibit glycolysis. In contrast, Crosset al.-(1996) observed that high pre-ischaemic 
glycogen levels in a low flow model delayed the onset of ischaemic contracture, but was 
also associated with poor recoveries. If however these hearts were reperfused prior to 
the onset of IC, recoveries improved to 89%. This led to the proposal that in the 
absence of glucose during ischaemia, depletion of glycogen would lead to reduced 
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glycolytic activity and subsequent accumulation of protons. On reperfusion, this build-up 
of protons increases sodium (Na+}/hydrogen or) exchange which provokes poor 
recoveries of function. Thus the effect of high tissue glycogen during ischaemia may 
depend on the degree of ischaemic coronary flow which ensures washout of harmful 
metabolites as well as the extent of ischaemic glycogen depletion. 
2.3.2 Fatty Acids (FA) 
Fatty acids (FA) are the preferred metabolic fuel in the perfused rat heart (Shipp et aI., 
1961). Intracellular FA must be transported into the mitochondria before it can be 
metabolised. This process involves three stages. In the first stage the F A undergoes 
esterification to yield fatty acyl-CoA. The acyl group is then transferred to the carrier 
molecule, carnitine, and transported across the mitochondrial membrane as fatty acyl 
carnitine. Once in the mitochondrion, the acyl group is transferred to intramitochondrial 
CoA. The acyl CoA then undergoes f3-oxidation where acetyl CoA units are removed 
from the fatty acid and finally incorporated into the Krebs Cycle (Neely and Morgan, 
1974). Acetate, a fatty acid homologue without detergent properties (Bricknell and 
Opie, 1978) is a two carbon compound which does not undergo f3-oxidation. Instead, it 
supplies acetyl-CoA directly to the Krebs Cycle (Mathews and van Holde, 1990 p.491-
493). This increased production of acetyl CoA accompanying fatty acid oxidation 
-- ---- --
inhibits pyruvate dehydrogenase complex (Figure 2.2), thus limiting carbohydrate entry 
into the Krebs Cycle (Braunwald, 1992 p.1183). 
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Figure 2.2 Glycolysis and the Krebs Cycle. * denotes where the glycolytic pathway has been condensed. (Adapted from 
Braunwald, 1992 p.1183) 
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Increased catecholamine stimulation experienced during ischaemia, contributes to the 
intracellular accumulation of FA via the breakdown oftriglycerides (Opie, 1968). These 
high levels of F A are detrimental to the ischaemic myocardium (Opie, 1975). Oxidation 
of FA during ischaemia is impeded by the O2 shortage (Neely and Morgan, 1974), and if 
B-oxidation is inhibited, unoxidised products such as acyl CoA and acyl camitine 
accumulate intracellularly. These products may have deleterious effects in the 
myocardium. 
Mechanisms involved in fatty acid toxicity include acylcarnitine induced inhibition of the 
SR Ca++ pump, inhibition of the sarcolemmal Na+/Ca++ exchanger and Na+-K+ pump, as 
well as activation of the Ca ++ channels. These actions could promote intracellular Ca ++ 
overload (Oliver & Opie, 1994). Furthermore, accumulation of acyl-CoA inhibits ATP 
transfer from the mitochondria to the cytoplasm (De Leiris et aI., 1975) (Figure 2.2). 
ATP produced in the mitochondrion is therefore inaccesible to the contractile apparatus 
and the sarcolemmal membrane pumps. Besides hindering ATP production (Opie, 
1975), accumulation of tissue FA contributes to K+ loss by opening KATP channels (Kim 
and Duff, 1990), depresses contractility (Davies et aI., 1992) and are arrhythmogenic in 
isolated rat hearts (Makiguchi et aI., 1991). Since an intracellular ATP deficiency 
promotes the release of enzymes (Wilkinson and Robinson, 1974), increased provision of 
F A could indirectly accelerate enzyme release from infarcting tissue. The magnitude of 
enzyme release has been associated with the ultimate extent of heart cell necrosis (De 
Leiris et aI., 1975). 
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2.4 Messengers during ischaemia 
The function of all cells is controlled by signalling systems which translate external 
information into internal signals (Berridge and Irvine, 1984). The first step in this 
pathway is the binding of the chemical messenger to the receptor. The myocardium 
possesses a- and (3-adrenergic receptors, each activating different signal transduction 
pathways. The (3-adrenergic system activates adenylate cyclase to generate cAMP as 
second messenger (Sutherland et ai., 1968; Schomig et ai., 1990 p.396). The a-
adrenergic system generates inositol trisphophate and diacylglycerol as second 
messengers. . These signalling systems regulate intracellular Ca ++~ which coincidentally 
rises during ischaemia, therefore implicating the involvement of these systems in 
ischaemic injury. 
2.4.1 Inositol 1, 4, 5-trispbosphate (IP3) 
When stimulated, the a-adrenergic receptor couples to a G-protein (Piper, p.396 1990; 
Vander et ai., 1990 p.160). The G-protein has a-, (3- and -S-subunits. Once coupled to 
the receptor, the a-subunit separates from the f3-S - subunit and appears to activate 
phospholipase C (Berridge, 1984). Phospholipase C catalyses the breakdown of 
phosphatidylinositol 4,5-biphosphate (PIP2), an inositol lipid located on the inner leaflet 
of the plasma membrane (Berridge and Irvine, 1984). As a result two second 
messengers, diacylglycerol (DAG) and inositol 1,4,5 - trisphosphate (IP3) are formed 
(Berridge, 1984). These messengers are produced rapidly, they function in a synergistic 
manner and act at very low concentrations. Levels of these signals depend on their rate 
of formation and degradation. Inositol trisphosphate is degraded through its conversion 
to IP2 by inositol triphosphatase while DAG is either phosphorylated to phosphatidic acid 
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by diacyl glycerol kinase, or deacylated to monoacylglycerol by diacyl glycerol lipase 
(Berridge, 1984). 
DAG and IP3 function as second messengers to activate two independent, but parallel 
signalling pathways. DAG remains in the membrane and activates protein kinase C 
(Berridge, 1984). Protein kinase C may act on numerous proteins such as the Ca++ 
ATPase, Na+-K+ ATPase, Na+,Il-( exchanger, the glucose transporter, troponin T and I, 
glycogen phosphorylase kinase and phosphofructokinase. Protein kinase C has·also been 
implicated in the regulation of contraction by phosphorylation of substrates and 
modulation of Ca ++ and other ion levels with inotropic and chronotropic effects. 
In contrast, IP3 mobilises Ca ++ from intracellular stores, particularly the SR (Berridge & 
Irvine, 1984). The Ca ++ releasing property of IP3 was first demonstrated in a preparation 
of rat pancreatic acinar cells (Streb et aI., 1983). This observation has been verified in a 
number of cell types including cardiac micro somes (Hirata et aI., 1984). It is not certain 
how IP3 increases internal Ca ++. It occurs either by acting on internal receptors to 
stimulate release, or inhibiting uptake mechanisms responsible for the removal of 
intracellular Ca ++ into the SR (Berridge, 1984). IP3 leveis decrease during ischaemia, but 
rise rapidly during reperfusion and may playa role in the harmful accumulation of Ca ++. 
2.4.2 Cyclic Adenosine 3,5 - monophosphate (cAMP) 
The 13-adrenergic system activates adenylate cyclase to generate cAMP as a second 
messenger (Sutherland et aI., 1968; Schomig et aI., 1990). G-proteins also playa role in 
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the formation of cAMP. If stimulated, the G-protein (Gs) couples adenylate cyclase to 13 1 
and 132 adrenoreceptors as well as other stimulatory receptors such as histamine and 
prostacyclin receptors. If inhibited, the protein (Gi) couples the cyclase to inhibitory 
receptors such as Al adenosine receptors and M2 cholinergic receptors (Opie, 1992). 
Increased cAMP levels occur due to greater formation from ATP (Wollenberger et aI., 
1969), or reduced removal/hydrolysis to 5-AMP by phosphodiesterase (PDE), or a 
combination of the two (Sutherland et aI., 1968). According to Podzuweit et al. (1996), 
the accumulation of cAMP in the ischaemic heart is partly due to metabolic activation of 
adenylyl cyclase and or inhibition of phosphodiesterase activity. 
Cyclic AMP plays a role in the myocardium's positive inotropic response to 
catecholamines (Sutherland et aI., 1968). It activates protein kinase A which then 
phosphorylates various proteins such as the sarcolemmal Ca++-channels and 
phospholamban. Phosphorylation of the voltage-gated Ca ++ -channels in the cell 
membrane opens these channels. The resultant influx of Ca ++ triggers additional Ca ++ 
release from the SR via a process known as calcium induced calcium release. This 
increased cytosolic Ca ++ level ultimately contributes to a stronger contraction. 
Phosphorylation of phospholamban, a regulatory protein on the SR, leads to enhanced 
activity of the Ca++ -ATPase which is responsible for transporting Ca++ back to the SR 
(Katz, 1988). Therefore cAMP also ensures that Ca++ is returned to the SR more rapidly 
thereby shortening the duration of the myocardial contraction. 
The rise of cAMP in the ischaemic zone has an arrhythmogenic effect (podzuweit et aI., 
1976). The cAMP hypothesis postulates that cAMP plays an important role in the 
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mediation of adrenergic effects on the heart's vulnerability to fibrillation. Elevated 
cAMP levels increases intracellular Ca ++ which then acts as a third messenger (Podzuweit 
et al.,1976) and promotes delayed after depolarisations (Coetzee et aI., 1987). It has 
been proposed that fl-blocking agents (e.g. propranolol) can reverse the arrhytl:unogenic 
effects by inhibiting the binding of catecholamines to the fl-receptors (Katz, 1977). 
Beta- blockade would limit an increase in cAMP levels (Wollenberger et aI., 1969), 
reduce cytosolic Ca ++ overload and help prevent ventricular fibrillation in the early stages 
of acute myocardial infarction (Lubbe et al., 1992). 
Evidence exists against the theory of the relation between tissue cyclic AMP levels and 
ventricular fibrillation. Metoprolol, a B-adrenergic blocker, failed to reduce the cAMP 
levels in the ischaemic myocardium (Muller et aI., 1986), while forskolin induced 
increases in cAMP levels in isolated rat hearts which were not accompanied by 
ventricular fibrillation (Manning et aI., 1985). Muller et a1.(1986) tested the relationship 
between the effects of B-blockade on ventricular fibrillation and tissue metabolic changes 
in the pig model. They found an initial rise and subsequent fall in cAMP levels and 
suggested that elevated cAMP could only be partially blocked by B-blockade possibly 
due to the inhibition of phosphodiesterase by intracellular acidosis. The subsequent 
reduction in cAMP may be due to downgrading or "switching off" of the B-receptors or 
links in the receptor -cyclase-cAMP chain. 
High cAMP levels are also associated with the regulation of energy generating pathways. 
In cardiac muscle, glycogen turnover may be controlled by intracellular levels of cAMP 
(Neely arid Morgan, 1974). It catalyses the phosphorylation of phosphorylase b to a, 
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thereby facilitating the conversion of glycogen to glucose-I-phosphate. Under energy-
deprived conditions, 5' -AMP may accumulate and also stimulate glycogenolysis by 
activating phosphorylase b. cAMP inhibits glycogen synthesis (Mathews and van Holde, 
1990 p.464) and enhances glycolysis by stimulating PFK activity (Katz, 1977 p.421). 
Together with adenosine, cAMP also inhibits fatty acid metabolism in oxygen deficient 
hearts. This may have an energy sparing effect by limiting the undesirable accumulation 
of long ~hain acyl-CoA derivatives (Neely and Morgan, 1974). 
2.5 Metabolic consequences of myocardial ischaemia 
2.5.1 Adenosine triphosphate (ATP) 
ATP is essential for most cellular processes. It is a source of energy for muscle 
contraction and the specific transport of substances across the cell membrane (Mathews 
and Von Holde 1990 p.83). It plays an integral role in the maintenance of ATP-
dependent pumps such as the K+ - channel and the Ca ++ - channel and is utilised to form 
cAMP. Furthermore, ATP may act as a vasodilator, either directly or by conversion to 
adenosine (Kirsch et al., 1990; Ferrari and Opie, 1992). Thus, the lack of energy during 
an oxygen deficiency may be the main cause of all functional and structural changes 
(Spiekermann, 1990). 
The initial reduction in work output during ischaemia occurs without any change in 
cellular ATP (Hoerter et ai., 1988). Only after the myocardial O2 pressure falls to low 
critical values, does breakdown of high energy phosphates occur. This initially includes 
mainly creatine phosphate (CP) and a little ATP. Anaerobic glycolysis is now stimulated 
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(Spiekermann, 1990) by the products of ATP degradation, ADP and Pi (Rovetto et al, 
1973). ATP usually inhibits the activity of citrate synthase, phosphorylase and PFK 
(Figure 2.2). Therefore an ATP shortage, as well as increased formation of intracellular 
activators such as AMP, serve to enhance glycolytic flux (Neely & Morgan, 1974). 
Mild ischaemia accelerates glycolytic flux leading to increased ATP production (Ferrari 
and Opie, 1992). During severe ischaemia however, carbohydrate flux through the 
Krebs Cycle is inhibited by the oxygen shortage and results in lactate accumulation 
(Rovetto et aI., 1973). The extent of lactate accumulation depends on the severity of 
coronary flow restriction and thus washout of metabolites. Together with protons, 
lactate hinders glycolysis by inhibiting glycolytic enzymes such as PFK, HK, and G3PDH 
(Neely et aI., 1975). Furthermore, lactate formation results in acyl CoA accumulation 
which in tum inhibits adenine nucleotide translocase. The latter is responsible for 
transporting ADP from the cytoplasm to the mitochondrion and ATP in the opposite 
direction (Rovetto et aI., 1975). As a result, there may be "insufficient ADP in the 
mitochondrion for ATP synthesis as well as insufficient ATP in the cytoplasm for cellular 
processes. These actions contribute to an ATP shortage. 
ATP helps maintain ion concentrations and pumps such as the KATP , the SR Ca++ pump 
and the sarcolemmal Ca++ channel amongst others. An ATP shortage would therefore 
result in opening of the KATP channels causing K+ loss from the cell (Norna, 1983). Since 
ATP is needed for Ca ++ uptake by the SR and Ca ++ extrusion by the sarcolemma in order 
to maintain a relaxed state (Opie, 1990), an ATP deficiency would lead to intracellular 
Ca ++ accumulation which may induce ischaemic contracture (Koretsune and Marban, 
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1990; Ventura-Clapier and Veksler, 1994). An ATP shortage also promotes enzyme 
release (Wilkinson and Robinson, 1974) while ATP degradation may liberate protons 
which in turn causes acidosis (Opie, 1989), both of which contribute further to necrosis 
of the ischaemic tissue. 
The breakdown of ATP to AMP and ADP during ischaemia may be potentially 
beneficial. Protective effects include mediating vasodilation by means of the formation of 
adenosine from AMP (Kirsch et aI, 1990), reducing heart rate and contractility by 
opening the KATP and inhibiting the Ca ++ current (Isenberg and Belardinelli, 1984; Opie, 
1992). 
Gross ATP content may however not be the most critical determinant of ischaemic 
injury. Neelyet al. (1973) found that the ATP content ofischaemic tissue had decreased 
by only 25 % by the time ventricular pressure started to decrease. They suggested that 
the ventricular failure may be due to compartmentalisation of available ATP in an 
inaccessible pool rather than a net shortage of ATP. By the time ischaemia had become 
irreversible, the ATP content had been further reduced by 70%. Since non-ischaemic 
tissue functioning at low ATP levels is not irreversibly impaired, they proposed that the 
ATP depletion is indicative, rather than a cause of irreversible ischaemic tissue damage. 
Alternatively, the turnover rate of high-energy phosphates may be more important in 
predicting the survival of the ischaemic myocardium (Vanoverschelde et aI., 1994). 
However, this may be limited by the loss of tissue nucleosides (Mustafa et aI., 1975). 
During net ATP hydrolysis, there is a loss of purine bases from oxygen deficient cells. 
This limits the restoration of ATP during reperfusion (Reibel and Rovetto,1978). If 
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however residual glycolysis is maintained, some ATP may be resynthesized thereby 
preventing the complete degradation of ATP and subsequent purine loss (Podzuweit et 
al., 1998). This supports the proposal that the extent to which ATP returns to control 
levels following a period of ischaemia may depend on how long ATP is maintained at a 
low level (Reibel and Rovetto, 1978). 
2.5.2 Lactate 
Under aerobic conditions, the myocardium extracts lactate from arterial blood to serve as 
a metabolic substrate (Braunwald 1992 p. 1183). In mild ischaemia, glucose and 
glycogen is converted to pyruvate where some is oxidised and some forms lactate. 
These are features of mixed aerobic and anaerobic metabolism. During severe ischaemia 
however, reduced oxygen availability prevents pyruvate flux through the Krebs Cycle. 
Lactate extraction is therefore reduced and replaced by net lactate production. 
Restriction of Krebs Cycle activity also results in acetyl CoA accumulation (Ferrari and 
Opie, 1992) which in turn inhibits the pyruvate dehydrogenase complex. The Qutcome is 
a greater conversion of pyruvate to lactate (Neely and Morgan, 1974). Severely 
restricted coronary flow where washout of metabolites is reduced may also contribute to 
lactate build up. 
Deleterious effects of lactate accumulation include the inhibition of glycolysis at various 
steps. It inhibits the G3PDH reaction (Figure 2.2) responsible for converting 3-
phosphoglyceraldehyde to 1.3-biphosphoglyceraldehyde (Williamson et al., 1976). High 
intracellular lactate levels also inhibit HK, PFK, phosphorylase kinase (which activates 
phosphorylase b to the a form) and carnitine acyl tranferase, responsible for the transfer 
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of acyl CoA from the cytoplasm to the mitochondria (Rovetto et at, 1973). The 
resultant build up of acyl CoA suppresses the activity of adenine nucleotide translocase, 
thereby inhibiting the exchange of ADP and ATP between the cytoplasm and 
mitochondria (De Leiris et al., 1975). According to Neely and Grotyohann (1984), high 
ischaemic lactate levels have also been inversely related to recovery of myocardial 
function during reperfusion. Thus, it appears that the glycolytic rate could be enhanced 
(Neely and Morgan, 1974) and reperfusion recoveries improved ifwashout oflactate and 
protons is accelerated. 
It has been reported that high levels of tissue lactate may contribute to intracellular 
acidosis (Brachfeld, 1969). More recently Dennis et at (1991) suggested that protons 
during ischaemia is more likely to be a result of reduced mitochondrial ATP production 
in relation to glycolytic ATP synthesis. Nevertheless, acidosis could also possibly 
increase intracellular Ca++ and aid the development of ischaemic contracture (Allen, 
1988). It inhibits glycolytic flux and the malate";aspartate cycle, responsible for the 
transport of oxaloacetic acid from the mitochondria to the cytoplasm (Williamson et at, 
1976). In addition, it is suggested that a low intracellular pH may contribute to 
ventricular failure. Accumulation of intracellular W may interfere with the uptake and 
release ofCa++ from the SR (Nakamura and Schwartz, 1972), or may compete with Ca++ 
for receptors on the troponin molecules, thus impairing the actin-myosin interaction 
(BraunWald, 1992). 
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2.5.3 Ionic changes 
a) Calcium (CaJ 
Calcium plays an important role in the regulation of the energy metabolism of cardiac 
muscle. Disturbances in the amount and distribution of intracellular calcium affects the 
energetics of myocardial cells (Henry et aI., 1977) whilst Ca ++ "out of control" is said to 
be harmful to cardiocytes (Poole-Wilson et al., 1984). 
Cell membranes are permeable to Ca ++ and since the ratio of the extracellular to 
intracellular free Ca++ is of the order of 10 000, the low intracellular Ca++ ion 
concentrations (~ 10 - 7 M) in myocardial cells must be maintained by active processes 
(Henry et aI., 1977). Under normal physiological conditions, the myocardial cell has a 
complex system to control the transsarcolemmal Ca++ fluxes. This includes the Ca++ 
ATPase pumps, the sodium potassium (Na+ -K+) ATPase pumps, the Na+/Ca++ exchanger, 
the Na+fI(" exchanger, and the L-type Ca++ channel. If these processes are disrupted, 
Ca ++ accumulates within the cell (Henry et aI., 1977) with detrimental effects for the 
survival of the myocardium. 
Intracellular Ca ++ concentrations increase through fi-adrenergic cAMP mediated influx 
via the slow Ca++ channels (Podzuweit et aI., 1978) and by a.-adrenergic IP3 mediated 
effects on the SR (Schomig et aI., 1990). Ca++ entry via the slow channels increase 
intracellular Ca ++ levels further by inducing Ca++ release from the SR. Catecholamine fi -
adrenergic stimulation also enhances Ca ++ uptake by the Ca ++ pump into the SR which 
leads to a greater rate of relaxation, termed the lusitropic effect (Katz, 1988). Ca++ 
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regulates cellular processes through the phosphorylation of various proteins and is 
therefore generally regarded as a third messenger, with catecholamines as first and 
cAMP / IP3 as second. Taking into account the various intervening processes including 
activation of protein kinases, Cart may sometimes be considered as the fifth or sixth 
messenger (Opie, 1992). 
According to Bricknell and Opie (1978), the early rise in cytosolic Cart may be from 
internal sources such as the SR, While the late rise is due to influx through the damaged 
sarcolemma (Opie,1987). Raised intracellular CaH levels may be the result of increased 
catecholamine secretion or reduced ATP stores. An ATP shortage hinders the Na+-K+ 
pump activity which in tum increases the intracellular Na+ concentration. To rectify this, 
activity ofthe Na+-Ca++ exchanger is enhanced resulting in greater Ca++ influx. An ATP 
deficit also inhibits the SR Ca ++ pump with reduced Ca ++ uptake into the SR and egress 
from the cells (Sedlis et aI., 1983). 
Deleterious effects of raised intracellular Ca ++ levels includes activation of Ca ++ -
dependent ATPases which encourages ATP degradation (Burton et aI., 1981), activation 
of Cart dependant lipases and proteases (Burton et al., 1981) leading to sarcolemmal 
phospholipid degradation, and release of arachidonic acid (Murphy et aI, 1985). It also 
promotes glycogen degradation by enhancing the conversion of phosphorylase b to the a 
form (Neely & Morgan, 1974), where the latter is responsible for converting glycogen to 
glucose-I-phosphate. Cart loading of the mitochondria contributes further to the ATP 
shortage by impairing ATP synthesis (Jacobus et aI., 1975). Moreover, elevated 
cytosolic Ca ++ precipitates arrhythmias by promoting delayed after-depolarisations 
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(Coetzee et aI., 1987). Thus, excess intracellular free Cart not only enhances ATP 
utilisation and decreases ATP production, but also causes membrane damage with Ca ++ 
overloading, and arrhythmias (Burton et aI., 1981). 
b) Sodium (Na+) 
Maintenance of the resting membrane potential (RMP) is crucial in cell viability since the 
Na+ and Cart channels fail to open when the cell is completely depolarised. The Na+-K+ 
pump is one of the basic mechanisms in maintaining the potassium (K+) gradient and 
resting membrane potential across the sarcolemma and responds to ATP in the 
micromolar range (Niki et aI., 1989). 
Variations in intracellular Na+ levels occur mainly through the Na+-K+ pump and Na+1 
Ca ++ exchangers which are reversible depending on concentration gradients of these ions. 
The ATP dependent Na+-K+ pump is usually responsible for the transport ofK+- into the 
cell and Na+ in the opposite direction in order to maintain the RMP. Failure of this pump 
during ischaemia due to energy depletion results in raised intracellular Na+ levels and 
lower K+ levels. This increased cytosolic Na+ levels now reduces the Na+ 
electrochemical gradient to such an extent that it can no longer drive Ca ++ extrusion via 
the Na+/Ca++ exchange. As a result, the exchange reverses and Na+ extrusion is coupled 
- •• _._ - __ __ 0-
to Cart ingress (Sedlis et aI., 1983). A low intracellular pH may also increase the 
cytosolic Na+ concentration through the Na+~ exchanger. This would then also 
contribute to subsequent Ca ++ accumulation via the N a + ICa ++ exchanger (Aronson, 
1985). Thus cytosolic Na+ imbalance precedes the cytosolic Cart rise (Allshire and 
Cobboid, 1990) with developed tension being strongly dependent on Na+. Additional 
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deleterious effects ofNa+ accumulation may include increased osmolarity, cell swelling, 
disruption ofthe RMP and generation of abnormal action potentials. 
c) Potassium (K+) 
The separation of ions across the semi-permeable sarcolemma is responsible for the 
resting membrane potential. Potassium has a higher intracellular concentration and as a 
result tends to move down the concentration gradient to the extracellular space. It plays 
a role in the maintenance of the RMP by creating a positive charge outside the cell 
During the action potential, K+ efflux: is retarded and contributes to the depolarisation of 
the sarcolemma. Opening ofthe K + channels permits ions to leave the cell thereby aiding 
repolarisation (Katz 1977 p.245). 
Rapid K+ loss is characteristic of the early phase of ischaemia but is not associated with 
detectable membrane damage. Late ischaemic K+ loss is due to severe ATP depletion 
and inhibition of the Na+-K+ pump which transports K+ back into the cell (Opie, 1987; 
1989). There are various hypotheses for the mechanism of K+ loss. Firstly, production 
of negatively charged lactate and inorganic phosphates occur due to anaerobic glycolysis 
and CP/ATP breakdown respectively. The positively charged K+ accompanies the 
negatively charged ions when leaving the cell in order to balance the charges (Kleber, 
1984). K+ loss may also occur via inhibition of the Na+-K+ pump (Sedlis et aI., 1983), 
and through opening of the ATP sensitive K+ channels (Noma, 1983) as a result of an 
ATP deficiency. 
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ATP-sensitive potassium channels (KATP) exist in numerous tissues including skeletal 
muscle, smooth muscle, the brain (Spruce et aI., 1985) and cardiac myocytes (Noma, 
1983). Channel closure is caused by the association of one ATP molecule with the 
intracellular ATP receptor in the channel (Nichols et aI., 1991). Adenosine diphosphate 
(ADP) has less effect than ATP in this aspect, whereas AMP has no effect on the KATP 
(Noma, 1983). Other intracellular ligands known to open the KATP are nucleoside 
diphosphates, protons and lactate (Findlay, 1994). Under normal conditions the channel 
is closed by intracellular ATP where ATP hydrolysis is compensated for by ATP 
production, and levels of other channel effective metabolites would be low. Ischaemia is 
characterised by an ATP deficiency and increased levels of ADP, protons and lactate. As 
a result, the KATP opens and affects myocardial contractility by lowering the RMP 
(Hollard et aI., 1977) and reducing the action potential duration. Furthermore, 
extracellular K+ is high in the ischaemic zone whereas it is lower (less elevated or 
normal) in the non-ischaemic zone. The current resulting from this K+ gradient is known 
as depolarisation-induced automaticity (Mugelli et aI., 1983). 
Openers ofKATP include cromakalim, pinacidil, isimakalim, levcromakalim and nicorandil 
(Cavero and Premmereur, 1994; Grover, 1994) while sulphonylurea drugs inhibit the 
opening of KATP (Findlay, 1994). Most studies indicate that KATP openers protect 
mechanical functioning of the heart, but are pro arrhythmic while KATP blockers are anti-
arrhythmic but are also associated with a greater loss of mechanical function (Siegl, 
1994). However the notion that openers of the KATP channels are pro arrhythmic and 
blockers are anti-arrhythmic is controversial as is whether KATP blockers or openers are 
of potential benefit in IHD (Cavero and Premmereur, 1994; Grover, 1994; Siegl, 1994). 
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2.6 Functional consequences of myocardial ischaemia 
2.6.1 Ischaemic contracture 
Ischaemic contracture (IC), defined as a 5% rise in diastolic tension (Owen et aI., 1990), 
is one of the earliest consequences of myocardial ischaemia. Within 10 seconds of the 
beginning of ischaemia, the systolic pressure is visibly depressed and ischaemic 
contracture develops once the systolic pressure is either greatly reduced or already 
abolished (Ventura-Clapier and Veksler, 1994). The clinical equivalent ofIC is known 
as the "stone heart" and is recognised as a complication of cardiopulmonary bypass 
(Cooleyet aI., 1972) and a marker for the onset of irreversible injury during coronary 
artery occlusion (Baroldi et aI., 1974). 
Hypothetically, IC may develop as a consequence of a raised cytosolic Ca ++ 
concentration (Bricknell and Opie, 1978) which causes active cycling crossbridges 
(Ventura-Clapier and Veksler, 1994). Thus the elevation of cytosolic Cart precedes the 
rise in resting tension (IC) during ischaemia (Kihara et al., 1989). Yet data indicate that 
reduced ATP availability correlates much better with the occurrence ofIC than changes 
in internal Cart (Koretsune and Marban, 1990; Owen et aI., 1990). An ATP deficiency 
prevents restoration of resting cytosolic Cart levels and inhibits dissociation of the actin-
_. _._- -- - -- --
myosin cross-bridges (Grossman and Barry, 1980). However, the exact relationship 
between ATP depletion and IC is not fully understood. It has also been suggested that 
phosphocreatine depletion and Mg++-ADP accumulation may contribute to the 
development of contracture in the ischaemic myocardium (Ventura-Clapier and Veksler, 
1994). 
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The development of IC is analogous with severe microscopic damage (Ap~tein et aI., 
1983) and massive cell disruption (Garcia-Dorado et aI., 1992). It may reduce the 
coronary flow even more via mechanical compression of the coronary bloodvessels 
(Humphrey et al., 1980). This would aggravate ischaemic injury by reducing washout of 
potentially toxic metabolites such as lactate or Ir (Neely & Groyohann, 1984). 
Ischaemic contracture contributes further to the progression of necrosis by raising the 
mechanical stress on adjacent myocytes through the intercalated discs (Garcia-Dorado et 
, 
aI., 1992). 
Different ischaemic substrates may influence the occurrence of IC. No incidence of IC 
was found during the ischaemic period in glucose perfused. hearts. Yet when glycolysis 
was inhibited with iodoacetatel deoxyglucose, or hearts were perfused with non-glucose 
substrates such as fatty acids, IC developed quickly (Bricknell and Opie, 1978; Van 
Rooyen et al., 1996). This supports the hypothesis that a certain rate of glycolytic ATP 
synthesis from glucose is needed for protection against ischaemic contracture in globally 
underperfused isolated rat hearts (Owen et aI., 1990). This may also explain why the 
protective effect of glucose on IC is lost during severe ischaemia when glucose delivery 
is limited (Rovetto et aI., 1973). Furthermore, ATP production via glycogenolysis may 
be less effective than glycolysis from glucose in maintaining Ca++ homeostasis across the 
sarcolemma. Some glycogen breakdown, is however required during the ear1y stages of 
low flow ischaemia to delay the onset ofIC (King et aI., 1995). 
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2.6.2 Arrhythmias 
Ventricular fibrillation is the most common cause of sudden cardiac death (Opie, 1987). 
A number of consequences of ischaemia have been shown to be potentially 
arrhythmogenic: 
1) increased adrenergic activity (Harris et aI., 1954, Podzuweit et aI., 1976) 
2) localised K+ loss (Harris et al., 1954) 
3) insufficient glycolytic ATP (Russel and Oliver, 1979) 
4) elevated lactic acid levels (Wissner, 1974) 
5) accumulation of fatty acids and acyl CoA (Kurien and Oliver, 1970) and 
6) myocardial oxygen gradients during regional ischaemia that may cause 
inhomogeneous metabolic and electrical activity (Beck, 1958). 
Catecholamine stimulation increases the heart's vulnerability to ventricular fibrillation 
(Hoffinan et aI., 1955). Administration of norepinephrine during ischaemia has been 
shown to elicit tachycardia or fibrillation in a number of animal models such as the 
isolated rat heart (Lubbe et al., 1978), the dog (Opie et al., 1980), and the pig 
(Podzuweit, 1980). Similarly, when sympathetic activity is inhibited by either surgical 
denervation (Ebert et al., 1970), depletion of myocardial epinephrine stores (Meesman, 
1980) or blockade of the receptors (Sehti et al., 1973), there is protection against 
ventricular fibrillation. 
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Catecholamines induce arrhythmias by raising cAMP and Ca ++ levels (Opie, 1987). Both 
cAMP (Wojtczak, 1982) and Ca++ (De Mello, 1982) delay intercellular conduction as 
they augment the intercellular resistance. Elevation of cAMP levels in the ischaemic 
myocardium is found to precede ventricular fibrillation (Podzuweit et aI., 1978; Opie et 
aI., 1979). In the isolated heart, epinephrine as well as dibutyryl cyclic 3'-5'-AMP (a 
form of cAMP thought to penetrate the cell membrane) enhanced ventricular 
vulnerability to fibrillation (Lubbe et al., 1976; Lubbe et al., 1978). Furthermore, agents 
such as propranolol (Lubbe et aI., 1981) and adenosine (Lubbe et al., 1983) reduces 
myocardial cAMP levels in the ischaemic zone and protects against the occurrence of 
ventricular fibrillation. 
Hypokalaemia also plays an important role in provoking ventricular arr1;lythmias 
(Johansson and Dziamski, 1984). Increased extracellular K+ levels in the ischaemic zone 
slows conduction which in turn predisposes the heart to re-entrant arrhythmias (Janse et 
aI., 1987). Therefore, agents which diminish K+ loss also lessen ventricular fibrillation as 
observed in the pig by Muller et al. (1986). Due to the loss of cellular K+, extracellular 
K+ levels are higher in the ischaemic zone and less elevated or normal in the non-
ischaemic area. This concentration gradient may inspire a phenomenon known as 
depolarisation-induced automaticity (Mugelli et aI., 1983) which is also influenced by 
changes in the external Ca ++ concentration (Katzung, 1975). Hence, Ca ++ antagonists, 
which inhibit the Cart current, may also relieve arrhythmias by lowering the K+ loss and 
reducing the depolarisation-induced current (Johnson et aI., 1991). 
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2.6.3 Membrane damage 
Proposed mechanisms for early membrane damage include: 
• Unoxidised fatty acid metabolites (e.g. acyl CoA and acylcarnitine) accumulate 
within the cell and contribute to ischaemic damage via their detergent effect on the 
cell membrane (Kurien & Oliver, 1970) and inhibition of glycolysis (Liedtke, 1981). 
• The accumulation of Ca ++ within the cell partly activates phospholipases. These 
enzymes are responsible for the degradation of membrane lipids. 
• Oxygen free radicals contribute to membrane damage via the formation of lipid 
peroxide. They are derived in part from neutrophils (Lucchesi et at, 1995) and are 
formed during the ischaemic and reperfusion phases. 
As ischaemia progresses, the membrane undergoes more destruction. This leads to a 
greater release of intracellular enzymes and ultimately cell death (De Leiris et at, 1975). 
2.6.4 Coronary flow 
A close relationship exists between coronary flow, myocardial oxygen consumption and 
contractile performance of the heart where changes in coronary flow translate into 
changes in contractile performance (Vatner, 1980). Therefore, coronary flow rate during 
ischaemia is an important determinant of the degree of recovery upon reperfusion (King 
et aI., 1995) and the rate and extent of cell death (Schaper et aI., 1987). It is argued then 
that ischaemia, where the coronary flow is restricted, is more detrimental to cellular 
function and metabolism than anoxia, where the coronary flow is maintained at normal 
rates (Rovetto et aI., 1973). 
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The harmful effects precipitated by a restriction of coronary flow is due to the lack of 
washout of the interstitial space, as well as reduced delivery of oxygen and metabolic 
substrates to the tissue. The time to the onset of cell death may even be directly 
proportional to the restriction of flow (Neely et aI., 1975). King et aI. (1995) found that 
the severity of the reduction in coronary flow plays a critical role in the protective effects 
of glucose. In the globally ischaemic isolated rat heart, a coronary flow reduction of 
30% caused an increase in glucose uptake. A further 15 % reduction had less of an 
effect, but when coronary flow fell to 4-10 %, glucose uptake was inhibited (Rovetto et 
aI., 1973). Neely et aI. (1975), on the other hand, found that a 50 % reduction in 
coronary flow in the isolated working rat heart resulted in ventricular failure' within eight 
minutes of the decrease in coronary flow. Ischaemic flow rates less than 2 m1I minute 
resulted in glycolytic inhibition. Alternatively, coronary flow rates upon reperfusion may 
determine the rate and extent of cell death (King et aI., 1995). Although the myocardium 
is reperfused, the coronary flow may still be restricted by mechanical compression of the 
coronary arteries by ischaemic contracture. This suppresses reperfusion coronary flow 
(Humphrey et aI., 1980) with subsequent accumulation of deleterious products. 
It is important to note that in experimental models, isolated rat hearts are perfused with a 
Krebs-Henseleit bicarbonate buffer. This crystalline solution has a lower oxygen 
carrying capacity than blood so the coronary arterioles dilate maximally due to local 
control mechanisms. As a result, the coronary flow is higher than the in vivo rates and 
range between 10-15 ml/ minute (Neelyet at., 1975). The ischaemic coronary flow is 
artificially fixed in order to prevent a contracture-induced reduction in flow (Humphrey 
et aI., 1980; King et aI., 1995). 
Stellenbosch University  https://scholar.sun.ac.za
34 
2.6.5 Developed pressure 
There are numerous abnormalities of diastolic and systolic function during severe 
ischaemia which ultimately affects the developed pressure. These include a reduced 
relaxation rate, ischaemic contracture (Apstein et aI., 1983) and systolic failure 
(Miyazaki et aI., 1990). Systolic pressure decreases within seconds of the beginning of 
ischaemia (Ventura-Clapier and Veksler, 1994) which is followed by an increase in 
diastolic tension or ischaemic contracture. According to Ventura-Clapier and Veksler 
(1994), rigor tension (ischaemic contracture) or stiffuess under these circumstances, may 
appear as a "switch off" of energy expenditure for contraction. Besides lC, additional 
factors which have negative effects on developed pressure include high ischaemic tissue 
lactate levels (Neely and Grotyohann, 1984), glycolytic inhibition (Kusoka and Marban, 
1994), inhibition of oxidative phosphorylation (Weiss and Hiltbrand, 1985), and 
increased fatty acids. Glucose, on the other hand, has been shown to aid recovery of 
developed pressure (Coleman et aI., 1989; King et aI., 1995) following an ischaemic 
period. 
2.7. Reperfusion 
Clinical manifestations of myocardial ischaemia such as myocardial infarction or 
ventricular fibrillation, depends on metabolic changes that may be modified by 
reperfusion (Opie, 1987). Reperfusionimproves the myocardial metabolism via 
increased washout of harmful metabolic products (Neely and Grotyohann, 1984) and 
providing oxygen and nutrients to the ischaemic myocardium. However, it may also 
cause damage which is referred to as reperfusion injury. This is characterised by a 
spectrum of events which include stunning, reperfusion arrhythmias, microvascular 
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IDjury, and accelerated or reperfusion-induced cell necrosis (Opie, 1989). The 
mechanism of reperfusion injury appears to be metabolic in origin, related to either free 
radicals or excess accumulation of cytosolic Ca++ (Opie, 1987). It is suggested that 
.. 
reperfusion mediated events are largely a consequence ~f injury during ischaemia. 
Prevention of these ischaemic-specific events can effectively preclude reperfusion 
induced injury (Vanoverschelde et aI., 1994). 
Reperfusion stunning refers to depressed or delayed myocardial mechanical function 
which occurs when ischaemic tissue is reperfused. The mechanical function· should 
nevertheless return to expected levels with continued reperfusion (Braunwald and 
Kloner, 1982). The two main hypotheses for the cause of stunning are cytosolic Ca++ 
overload (Du Toit and Opie, 1992) and the formation of oxygen free radicals (Bolli, 
1990). Oxygen free radicals, derived partly from neutrophils, may playa role in stunning 
by reducing the response of the organelles to Ca ++ (Engler and Corell, 1987). When 
these free radicals are diminished by scavengers such as superoxide dismutase, improved 
recovery from ischaemia is found (Ambrosio et aI., 1987). 
Elevated Ca++ levels during reperfusion has been implicated as the mediator of 
postischaemic contractile dysfunction (Tani and Neely, 1989). The use of C~++ channel 
blockers or modulation of flux via the SR during early reperfusion has a protective effect 
and lessens stunning (Du Toit and Opie, 1992). Lazduski et ai. (1985) proposed that 
rapid washout of extracellular W during reperfusion may create an intracellular-to-
extracellular It" gradient. Via a cascade of events, which involve the Na+/lt and 
Na+/Ca++ exchangers, this W gradient is ultimately responsible for raising intracellular 
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Ca ++ levels. According to Jeremy et aI. (1992) the promotion of glucose utilisation may 
reduce stunning by increasing glycolytic ATP production which controls cytolsolic Ca++ 
levels. 
No-reflow is the phenomenon which occurs when removal of the coronary occlusion 
does not lead to the restoration of the coronary flow (Bernier et aI., 1986). There are 
two explanations for this phenomenon. Either the microvascular damage caused 
endothelial cell edema, or IC may have prevented normal flow by squeezing the coronary 
arteries (Opie 1991). The consequences of microvascular damage include reduced 
formation of vasodilatory substances such as nitric oxide, and formation of 
vasoconstrictory endothelin. Endothelial damage may also counteract factors which 
inhibit platelet plugging and neutrophil adherence (Forman et aI., 1989). 
Arrhythmias are an abnormal heart rhythm and is classified as ventricular arrhythmias or 
supraventricular arrhythmias. This includes tachycardias and bradyarrhythmias (Opie, 
1991). The mechanisms which may underly ventricular arrhythmias include automaticity 
(Hauswirth et aI., 1969; Mugelli et aI., 1983), reentry circuits (Janse et aI., 1987), and 
after-depolarisations. Reperfusion arrhythmias may also be due to excess cycling of 
intracellular Ca++( Coetzee et aI., 1987), and the formation of free radicals. Free radicals 
can induce electrophysiological changes such as membrane depolarisation (Coetzee et 
aI., 1990) and when present in high concentrations, can modify the gating properties of 
the SR so that excess Ca++ is released (Cumming et aI., 1990). This Ca++ overload 
triggers reperfusion arrhythmias (Opie, 1987) by promoting delayed after depolarisations 
(Coetzee et aI., 1987) and provoking inward depolarising currents (Johnson et aI., 1991). 
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The nature of the reperfusion solution may affect the incidence of reperfusion 
arrhythmias. The inhibitory effect of glucose on reperfusion ventricular arrhythmias is 
established (Manning and Hearse, 1984; Bernier and Hearse, 1988; Coleman et aI., 
1989). Recent findings include acidic reperfusion as having an inhibitory effect as well. 
Avkiran and Ibuki (1992) found that early acidic reperfusion significantly suppresses 
reperfusion induced ventricular fibrillation. The protection afforded was maximal at pH 
6,6 and the duration of acidic reperfusion needed to be at least two minutes. The 
protective mechanism oftransient acidic reperfusion may involve pH-mediated inhibition 
of Na+ influx and perhaps enhanced recovery of the Na+-K+ ATPase (Avkiran et aI., 
1996). 
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Chapter 3 
MATERIALS AND METHODS 
3.1 Animals 
Male Sprague-Dawley and Wistar rats were used. Each weighed between 260g-380g. 
The rats had free access to food (standard lab chow) and water. They were maintained 
in animal quarters at a constant temperature (22°C) and humidity (40%) with a twelve 
hour artificial light cycle. 
3.2 Study design 
The rats were anaesthetised with diethyl ether vapour (B and M Scientific). Once asleep, 
they were injected with 200U sodium heparin (Novo Nordisk) into the femoral vein. The 
heart was excised quickly and placed in ice cold Krebs-Henseleit solution. The isolated 
rat heart was then mounted on a cannula via the aorta and perfused within 60 seconds of 
the excision. The heart was subsequently freed of excess non-cardiac tissue. All hearts 
were perfused in accordance with the Langendorff technique with an oxygenated Krebs-
Henseleit bicarbonate buffer initially containing 5 mM sodium acetate as a substrate. The 
purpose of the acetate was to reduce pre-ischaemic tissue glycogen levels (Neely et aI., 
1970) and thus preclude its effects on performance during ischaemia. This initial 
perfusion period lasted 30 minutes, the purpose of which was to stabilise the heart and 
washout any blood and enzymes (De Leiris et al., 1975). A Gilson Minipuls 3 pump kept· 
the meniscus of the buffer at a constant level so as to maintain a perfusion pressure of 
100 em H20. The myocardial temperature of 37°C was maintained throughout the 
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experiment by means of a waterbath (CND Scientific) which circulated warm water 
through the water jacketed glass reservoirs. A thermistor probe was inserted into the 
right coronary sinus to monitor the myocardial temperature. Coronary flow rates varied 
between 10 - 15 mlImin. during normal perfusion of 100 cm H20. 
3.3 Experimental protocols 
The protocol consisted ofthree sequential periods lasting 30 minutes each (Figure 3.1): 
• 0 - 30 min.: During the pre-ischaemic phase, hearts were perfused under standard 
conditions at a pressure of 100 cm H20 (coronary flow: 10-15 mlImin.) with 5 mM 
sodium acetate (Ac) as a substrate. 
• 30 - 60 min.: During the ischaemic phase hearts were subjected to global low flow 
ischaemia. A Gilson Minipuls 2 pump regulated the coronary flow at a rate of 2 
mlImin. which was equivalent to a 80-87% reduction in flow rate, i.e. 13%-20% of 
the pre-ischaemic values. This ischaemic coronary flow rate was higher than what is 
usually employed in order to lessen the accumulation of harmful metabolites and 
ensure residual oxygen delivery. The ischaemic perfusate contained one of the 
following substrates: 10 mM Glu, 1 mM Ac, 5 mM Ac, 10 mM'Ac, or 30 mM Ac. 
Additional hearts were also subjected to an ischaemic period without residual oxygen 
(ischaemia-anoxia). The perfusate, containing either 5 mM Ac or 10 mM Glu, was 
aerated with nitrogen gas during ischaemia-anoxia instead of the oxygen-carbon 
dioxide mixture used in the previous experiments. 
• 60 - 90 min.: During the reperfusion phase hearts were perfused under standard 
conditions once again where the perfusion pressure was 100 cm H20 and the 
coronary flow rates varied from 10-15 mlImin. 
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3.4 Tissue Samples 
For the purpose of biochemical analysis, a number of hearts were freeze clamped with 
Wollenburger metal tongs which was precooled in liquid nitrogen. The first group (n = 
6) was freeze clamped at the end of the pre-ischaemic phase (30 minutes). Additional 
hearts were freeze clamped at the onset of IC (± 33 minutes), and at the end of the 
ischaemic phase (60 minutes). The exact time period between the beginning of ischaemia 
and the onset of IC varied depending on the substrate used during ischaemia. The 
ventricular tissue was then stored in a -80 °C freezer until analysed. 
3.5 Measured variables 
The variation in systolic and diastolic pressure was monitored through the insertion of a 
compliant balloon into the left ventricle. The balloon was made of plasticised PVC 
("Glad Wrap") and inflated with distilled water. Any alteration of the balloon's volume, 
caused by the contraction of the heart against the balloon, was converted to a pressure 
reading by a pressure transducer (Washington PT 400 SIN 173). This was recorded on a 
Washington 400 MD 2C oscillograph. The balloon's volume was maintained throughout 
the experiment. The onset of IC, as indicated by a 5 % increase in diastolic pressure 
above baseline, was followed by a continued rise in diastolic pressure. After the initial 
rise, a peak was reached and ensued by a gradual fall in diastolic pressure. This 
sigmoidal graph is characteristic ofIC. The time lapse from the start of ischaemia to the 
onset ofIC was measured. 
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PHASE: Pre-ischaemia 
TIME (MIN): 0 30 
*+ 
Ischaemia 
60 
+ 
Reperfusion 
41 
90 min 
~.----------------
CORONARY FLOW: 10-17 mlImin 
SUBSTRATE: SmMAc 
SmMAc 
5mMAc 
t 
2 mlImin 
1 mM Ac or 5 mM Ac or 
10 mM Ac or 30 mM Ac 
5 mM Ac or 10 mM Glu 
10-17 mlImin 
SmMAc 
SmMAc 
30 mM Ac or 10 mM glucose 5 mM Ac 
* 
Aim 1: To establish an optimal 
Ac concentration which best 
protects the heart during subtotal 
ischaemia 
Aim 2: To determine the effect 
of O2 availability during ischaemia 
on the beneficial effects of Glu and 
Ac 
Aim 3: To determine whether 
equi-carbon concentrations of 
Ac and Glu offer similar 
protection during subtotal 
ischaemia 
Figure 3.1 Study Design. (~ indicates the points at which hearts were freeze clamped; * indicates pressure readings used to determine % 
recovery of left ventricular developed pressure (L VDP); Ac=acetate, Glu=glucose) 
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Coronary flow (ml/min.) was measured periodically by collecting the volume of the 
heart's effluent in one minute. The coronary flow rate, heart rate (indicated by the 
ECG), and temperature was noted after five minutes of perfusion and every ten minutes 
thereafter. 
The pH and p02 of the perfusate was determined with a blood-gas analyser using 
samples taken from both the low flow and normal flow systems. 
Functional recovery, as indicated by the developed pressure at the end of the reperfusion 
period, was expressed as a percentage of the pre-ischaemic developed pressure after the 
initial 30 minutes of perfusion. 
3.6 Exclusion criteria 
Hearts with coronary flow rates outside the range of 10 - 17 ml/min., and heart rates 
outside the range of200-380 beats/min were excluded. The temperature was maintained 
within one degree more or less than 37°C. 
3.7 Perfusion solutions 
The perfusion solution, a crystalloid Krebs-Henseleit bicarbonate buffer, contained 118.5 
mM NaCI, 25.0 mM NaHC03, 4.8 mM KCI, 1.2 mM KH2P04, 1.2 mM MgS04.7H20 
and 1.3 roM CaCh.2H20 (Merck). The solution was aerated with 95 % O2 ; 5 % CO2 
for fifteen minutes prior to the experiment as well as throughout the protocol. The 
substrates used during ischaemia were 10 mM glucose (Merck) and 1 mM or 5 mM or 
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10 mM or 30 mM sodium acetate (Sigma) while 5 mM sodium acetate was also used 
during the pre-ischaemic and reperfusion phases (Figure 3.1). Solutions were filtered 
with a Milli-Q-System obtained from Millipore (cat. no. HVLP04700). Buffers were 
prepared and stored in a fridge on the previous day and filtered through 0.45 pm 
millipore filters just prior to usage. 
A sample of the perfusate was taken prior to the experiment to determine pH and P02• 
The low flow system had a pH =7,45 and P02 =64.4 kPa. The perfusate in the high flow 
system had a pH =7,45 and P02 =63.0 kPa .. 
3.8 Biochemical analysis 
The ventricular tissue was freeze-dried (Christ Alpha 1-4 freeze-dryer) and teased in 
order to obtain a homogenous sample. The tissue was then extracted with either KOH 
(3.8.1) to determine its glycogen levels, or with perchloric acid (3.8.2), to determine the 
ATP, creatine phosphate, lactate and cAMP levels. All metabolite concentrations were 
assayed enzymatically with the use of a spectrophotometer or radioimmunoassay kit. 
3.8.1 Glycogen extraction 
-.-.~.- ----.~--- -_. --- _.. -
1. Add ± 10 mg of the freeze-dried tissue to Eppendorftubes. (Note the weight of the 
tissue.) 
2. Add 0.2 ml40 % cold KOH 
Stellenbosch University  https://scholar.sun.ac.za
44 
3. Heat to 95°C on Eppendorf thermostat for 30 minutes, shaking at 10 minute 
intervals to ensure that the tissue is broken up. Place a weight on the lids to prevent 
them from popping open. Allow to cool. 
4. Add 0.8 mll 00% ethanol (ETOH). Glycogen precipitates overnight in the fridge. 
5. Spin for 3 minutes (Eppendorf centrifuge) at 4°C at 14000 rpm. 
6. Aspirate supernatant, wash pellet at least twice with cold 100% ETOH. Aspirate 
supernatant again. 
7. Add 1 ml acetate buffer with Img amyloglucosidase (7.3 U/ mg) to the pellet. 
acetate buffer: 0.2 M (l6.4g) sodium acetate + 4.8 ml 96% acetic acid 
8. Shake pellet well and then heat for 2 hrs at 37°C on the Eppendorf thermostat to 
hydrolyse the glycogen to glucose. Shake pellets intermittently. 
9. Add 75 ml PCA (70%) 
10. Spin for 3 minutes (Eppendorf centrifuge) at 14000 rpm 
11. Remove 1 ml clear supernatant/acid extract and place in clean Eppendorf tubes. Add 
350 ~12M NaOH for neutralisation. 
Use this neutralised sample to determine the tissue glucose levels by means of a standard 
assay. 
Calculations: 
Calculate the dilution factor (F). 
F = vol. PCA x total volume (ml) 
dry heart weight (g) 
where total volume = total neutralised vol. 
vol. of acid extract 
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3.8.2 Tissue extraction with perchloric acid (peA) 
1. Add 9-10 mg teased freeze-dried tissue to Eppendorf tubes. (Note the weight of the 
tissue.) 
2. Add cold PCA (5%) to tissue (50 J.!l PCAI mg dry tissue) and homogenise 
(Ultrasonic Disintegrator, Branson) sample immediately while keeping tube on ice. 
(Note the amount of PC A used.) 
3. Spin homogenised samples in the centrifuge (Eppendorf centrifuge) for 3 minutes at 
14000 rpm. 
4. Add the supernatant to a clean Eppendorf tube. (Note the exact volume of 
supernatant used.) 
5. Add 5 J.!l universal indicator and neutralise the acid extract with 5N KOH to pH 6.5-
7.5 (sample appears yellow-green in colour). (Note the amount of KOH used to 
neutralise the sample) 
6. Spin (Eppendorf centrifuge) samples for 3 minutes at 14000 rpm. 
7. Decant the supernatant into clean Eppendorfs and store at -196°C in liquid nitrogen 
Use this neutralised sample to determine the tissue ATP, CP, lactate and cAMP levels by 
means ofa standard assay. 
Calculations: 
Calculate the dilution factor (F). 
F = vol. PCA x total volume (mI) 
dry heart weight (g) 
total volume = vol. acid extract/supernatant used + vol. ofKOH used to 
neutralise the extract + 5 J.!l universai indicator 
Stellenbosch University  https://scholar.sun.ac.za
46 
3.8.3 Assays 
a) Adenosine triphosphate (ATP) and creatine phosphate (CP) 
Measurement of ATP and CP is dependent upon the following enzymatic reactions which 
result in the formation of NADPH. The variation in absorbance is measured with a 
spectrophotometer at 340 nm as NADP+ is reduced to form NADPH. The increase in 
absorbance is directly proportional to the creatine kinase activity. 
Creatine kinase (CK) 
CP + ADP ~ATP + creatine 
Hexokinase (HK) 
ATP + glucose ~ADP + G6P 
glucose 6-phosphate dehydrogenase (G6P DH) 
G6P + NAD~ 6-phosphoglucono-8-lactone + NADPH + W 
Cocktail Standard 
Reagent Vol/cuvette Reagent Vol 
Glucose (10mM) 100 ~l ATP (10 mM) 100 ~l 
NADP (10mM) 50 ~l (50 nmol/ 50 ~l) 
MgCI2 (1 M) 20~1 CP (10 mM) 10c!) ~l 
G6PDH (1 U/1.5 ~l) 1.5~1 H2O 800 ~l 
Tris (0.5 M; pH 7.5) 400 ~l 
_.- - -
_._-_ ... .. _. 
_._- - ._---"- --- - - -_._-- _ ... -_ .. 
H2O 379 III 
Total 950.5 ~l Total 1000 ~l 
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Assay: 
ATP 
1. Add 50 jll neutralised sample to 950 III cocktail 
2. Shake sample and wait 10 minutes 
3. Use a spectrophotometer to measure the baseline absorbance (E1) at 340 nm. 
4. Add 10 III hexokinase (3 U/ 10 Ill) 
5. Wait 30 minutes and then measure absorbance again (E2) 
CP 
6. Add 50 III ADP (10 mM) and wait 10 minutes 
7. Measure the baseline absorbance (E 1 ) 
8. Add 10 III creatine kinase (2 mg/ 500 III == 2 U/ 10 Ill) 
9. Wait 30 minutes and then measure the absorbance again (E2) 
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b) L-Lactate 
The measurement of lactate is dependant upon the following enzymatic reaction: 
Lactate dehydrogenase (LDH) 
Pyruvate + NADH +W~ Lactate + NAD+ 
Cocktail Standard 
Reagent voll cuvette Reagent vol 
NaOH(2M) 350 JlI Lactate standard (1 MI L) 20 Jll 
Hydrazine buffer 350 JlI (100 nmol! 50 JlI) 
NAD(lOmM) 100JlI H2O 980 JlI 
H2O 150 JlI 
Total 950 JlI Total 1000 JlI 
Hydrazine buffer: 26.02 g Hydrazinesulphur (lM) + 30.03 g Glycine (2 M) + 0.370 g 
EDTA (5 mM) + water to final volume of200 ml 
Assay: 
1. Add 50 JlI neutralised sample to 950 JlI cocktail 
2. Shake sample and wait 10-15 minutes 
3. Use a spectrophotometer to measure the baseline absorbance (E 1) at 340 nm. 
4. Add 10 JlI LDH (25 Jlgi 10 JlI) 
5. Wait 30 minutes and then measure the absorbance again (E2) 
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c) Glucose 
The measurement of glucose is dependant upon the following enzymatic reactions: 
Hexokinase (HK) 
Glucose + ATP~Glucose 6-phosphate + ADP 
Glucose 6-phosphate dehydrogenase (G-6-PDH) 
G6P + NADP ~6 phosphoglucono-cS-lactone + NADPH + W 
Cocktail Standard 
Reagent vol! cuvette Reagent vol 
ATP (10 mM) 100 J-li Glucose (10 mM) 100 J-li 
NADP(10mM) 100 J-li (50 nmol! 50 J-lI) 
MgCh (1 M) 20J-l1 H2O 900 J-li 
G-6-PDH (1U/1.5 J-lI) 1.5 J-li 
Tris (0.5 M; pH 7.5) 400 J-li 
H2O 329 JlI 
Total 950.5 J-li Total 1000 J-li 
Assay: 
1. Add 50 J.lI neutralised sample (from glycogen extraction) to 950 J-li cocktail 
2. Shake sample and wait 10 minutes 
3. Use a spectrophotometer to measure the baseline absorbance (E 1) at 340 nm. 
4. Add 10 J-li hexokinase (1. 5 J-li enzyme + 8.5 J-li buffer = 1 U I 10 J-lI) 
5. Wait 30 minutes and then measure the absorbance again (E2) 
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Calculations to determine the ATP, CP, lactate and glucose concentrations 
Llli = E2-El 
Concentration = Llli x F3 x cuvette voL 
E (6.3) x sample voL x d (=1) 
d) cAMP 
A kit (Amersham, England) was used to determine tissue cAMP content. The assay is 
based on the competition between unlabelled cAMP and a fixed quantity of tritium 
labelled cAMP for binding to a protein. This protein has a high specificity and affinity 
for cAMP. The amount of labelled cAMP-protein complex formed is inversely related to 
the amount of unlabelled cAMP present in the sample. Therefore by measuring the 
protein-bound radioactivity, the amount of unlabelled cAMP in the sample may be 
calculated. The protein bound cAMP is separated from the unbound nucleotide through 
the absorption of the free nucleotide onto coated charcoaL Through centrifugation, a 
supernatant is obtained and removed for liquid scintillation counting. A standard curve is 
used to determine the concentration of unlabelled cAMP in the sample. 
3.9 Statistical analysis 
A software package, GraphP AD Instat TM was used to conduct the statistical analysis. All 
data was expressed as means ± SEM. Each experimental group consisted of 6-8 .hearts. 
Results were compared using ANOVA two-way analysis of variance followed by the 
students t-test with p ~ 0.05 considered as significant. 
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Chapter 4 
RESULTS 
4.1 Aim 1: To establish an optimal acetate concentration which best protects the 
heart during subtotal ischaemia 
4.1.1 Heart rate (Table 4.1) 
After 25 minutes of pre-ischaemic perfusion, the heart rate (RR) in all groups ranged 
from 250-283 beats/min with no significant variation amongst the groups. After 5 
minutes of ischaemia the HR in all groups, except 5 mM Ac, decreased significantly; The 
greatest decline (p~0.001) was noted in the 1 mM Ac hearts where the HR deteriorated 
to only 18.8±0.7 beats/min and remained low throughout ischaemia. With initial 
reperfusion, heart rates .in 5 mM and 10 mM Ac treated hearts had recovered to 
265.8±1O.3 and 242.5±9.0 beats/min respectively. On the other hand, 1 mM Ac and 30 
mM Ac yielded significantly weaker recoveries of 60.0±0.O and 170.3±52.1 respectively. 
After 25 minutes of reperfusion, the HR in all groups except 1 mM Ac had recovered to 
at least 21O.8±43.0 beats/min. (84 % ofthe last pre-ischaemic recording) while 1 mM Ac 
hearts had recovered to only 160.0±80.0 beats/min. There was however no significant 
difference in HR amo ng sf the- groups· at this -point. 
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Table 4.1 Heart Rate (beats/min) at different stages during the experiment where 
various ischaemic substrates were administered. Ac = acetate, Glu = glucose. 
* p~0.05 vs 1 rnM Ac at the same time interval; # p~0.05 vs HR at 25 min in the same 
group. 
Time ImMAc 5mMAe 10 mM Ac 30 mM Ac 10 mM Glu 
Pre - 5 342.5±15.2 334.0±11.8 315.0±16.9 372.5±27.8 260.0±1104 
ischaemic 15 290.0±3.2 272.5±17.5 287.5±31.8 292.5±26.5 247.5±5.1 
Phase 25 252.5±19.1 270.7±13.8 282.5±17.1 250.0±26.5 257.5±10.5 
Ischaemic 35 18.8±0.7# 192.0±36.6* 145.0±19.2# 106.7±2404# 135.0±21.2 
Phase 45 17.4±1.1 188.3±26.1 125.0±28.6 57.5±13.6 127.5±22.8 
55 18.0±0.0 118.6±20.4 120.0±31.7 60.0±12.8 162.5±18.5 
Reperfusion 65 60.0±0.0 265.8±10.3* 242.5±9.0* 170.3±52.1 235.0±6.3 
Phase 75 60.0±0.0 270.8±13.0 285.0±27.7 174.7±53.7 257.5±7.2 
85 160.0±80.0'" 272.5±14.6 277.5±23.8 210.8±43.0 247.0±604 
'" The HR could only be determined for 2 of the 6 hearts at this particular time interval, 
hence the large SEM. The rest of the hearts fibrillated at this point. 
4.1.2 Coronary Flow (Table 4.2) 
Pre-ischaemic coronary flow (CF) was similar in all groups and ranged between 1204-
15.6 mlImin. During ischaemia, the CF was fixed at 2 mlImin. Upon reperfusion the CF 
returned to pre-ischaemi~ values and after 25 minutes ofreperfusion, the CF in all groups 
except 1 rnM Ac had recovered to at least 11.0±0.9 mlImin. (equivalent to a minimum of 
85% of the CF prior to ischaemia). There were no significant differences in CF at the 
end of the reperfusion period. 
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Table 4.2 Coronary flow (mllmin) at different stages during the experiment where 
various ischaemic substrates were administered. Ac = acetate, Glu = glucose. 
Time ImMAc 5mMAc 10 mM Ac 30 mM Ac 10 mM Glu 
Pre - 5 15.6±0.5 14.3±1.2 15.9±0.6 17.0±0.5 16.1±0.5 
ischaemic 15 13.3±1.0 13.6±1.1 14.0±1.2 14.3±0.7 14.4±±0.8 
Phase 25 12.4±1.2 13.8±1.4 13.2±1.1 13.0±0.8 13.5±0.5 
Ischaemic 35 2.02±1.7 2.0±2.6 2.0±2.6 2.0±1.7 2.1±2.6 
Phase 45 2.02±3.1 2.1±5.0 2.0±0.0 2.0±0.0 2.0±2.1 
55 2.05±2.2 2.0±2.6 2.1±2.2 2.0±1.7 2.1±3.1 
Reperfusion 65 10.1±1.1 12.2±1.3 12.0±1.0 9.6±0.7 13.2±0.8 
Phase 75 9.43±1.2 13.4±1.7 13.2±0.8 10.6±0.9 12.0±0.7 
85 9.1±1.3 13.6±1.7 13.4±1.0 11.0±0.9 11.6±0.5 
4.1.3 Time to the Onset oflschaemic Contracture (TOIC) (Figure 4.1) 
Ischaernic contracture was delayed in the 10 mM Ac hearts (202.0±0.04 s) while 30 mM 
acetate accelerated the time to onset of Ie (65.0±9.8 s). However, there was no 
significant difference between 5 mM and 10 mM Ac hearts and similarly between 1 mM 
and 30 mMAc. 
4.1.4 Percentage recovery of Left Ventricular Developed Pressure (LVDP) (Figure 
4.2) 
The percentage recovery ofLVDP--was-gieatest in 5 mM-Ac hearts (53.5±2.74 %) with 
1 mM Ac producing the weakest recoveries (5.0±2.9 %) (p:=50.001 vs 5 mM, 10 mM and 
30 mM Ac). Despite yielding the best recoveries, there was no significant difference 
between 5 mM and 10 mM Ac. 
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4.1.5 Tissue ATP content. (Table 4.3 and Figure 4.3) 
Tissue ATP levels in control hearts, which were freeze clamped after 30 minutes of pre-
ischaemic perfusion, was 22.2±O.5 umol/g d.w. Tissue ATP content decreased (p~0.05) 
at the onset ofIC in all Ac treated hearts and declined even further after 30 minutes of 
ischaemia with values ranging from 9.5±0.9 umol/g d.w (30 mM Ac) to 12A±1.0 umol/g 
d.w. (5 mM Ac). There was however no difference in ATP content amongst any of the 
groups at either the onset oflC or end of ischaemic period. 
4.1.6 Tissue CP content. (Table 4.3 and Figure 4.4) 
The tissue CP content prior to ischaemia was 39.56±OA2 umol/g d.w.. At the onset of 
IC it had decreased in all groups to values that ranged from 16.38±1.85 umol/g d.w (1 
mM Ac)to 20.91±1.16 umol/g d.w. (10 mMAc). By the end of the ischaemic period, 
the tissue CP levels diminished even further in the 10 mM Ac hearts. There were no 
differences in tissue CP content amongst the Ac hearts at the various intervals. 
4.1.7 Tissue Lactate content. (Table 4.3 and Figure 4.5) 
Tissue lactate level in control hearts measured 1.5±OA umol/g d.w. Lactate levels had 
increased (p~0.05) in all hearts at onset of IC, with the highest levels observed in the 
hearts treated with 30 mM Ac (7.0±0.9 umol/g d.w) and lowest in ImM Ac (3.28±0.37 
umol/g d.w) hearts. Tissue lactate levels in ImM Ac treated hearts were significantly 
lower than that of30 mM Ac at the onset ofIC. After 30 minutes of ischaemia the tissue 
lactate content of hearts perfused with 10 mM and 30 mM Ac increased even further. 
Differences within the groups was again only significant between 1 mM Ac and 30 mM 
Ac (p~0.01) at the end of the ischaemic period. 
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4.1.8 Tissue Glycogen content. (Table 4.3 and Figure 4.6) 
Glycogenolysis, as indicated by reduced tissue glycogen levels, had increased in all Ac 
hearts both at the onset of IC and after 30 minutes of ischaemia. The smallest decrease 
(p~0.05) in tissue glycogen at the end ofthe ischaemic period was observed in 5 mM Ac 
(12.6±3.4 umol/g d.w) with the largest decline (p~0.0005) noted in ImM (7.66±0.55 
umol/g d.w) and 10 mM Ac (4.8±1.2 umol/g d.w.). There were, however, no significant 
differences in tissue glycogen content amongst the Ac hearts. 
4.1.9 Tissue cAMP content. (Table 4.3 and Figure 4.7) 
Compared to cAMP levels prior to ischaemia, there was an increase in tissue cAMP at 
the onset of IC in all groups (p~0.01). The greatest increase was noted in hearts 
p~rfused with 30 mM Ac (4.1±0.3 nmol/g d.w) (p~0.0005) and was associated with a 
shorter time to the onset ofIC. cAMP levels at the end of the ischaemic period was not 
different to the control values. There was no significant variation in cAMP amongst the 
Ac hearts at either the onset oflC or after the 30 minutes of ischaemia. 
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Table 4.3 Tissue ATP, CP, lactate, glycogen, and cAMP content determined prior to ischaemia (30 min), at the onset of ischaemic 
contracture (OIC) and at the end of the ischaemic period (60 min). Ac = acetate; Glu = glucose 
Substrate ATP CP Lactate Glycogen cAMP 
I 
(u,mol/g d.w.) (umol/g d.w.) (umol/g d.w.) (umol/g d.w.) (nmol/g d.w.) 
30 min (control) 122.2±0.5 39.56±0.42 1.5±0.4 62.5±10.6 2.3±0.1 
OIC 1mMAc i6.11±0.8# 16.38±1.85# 3.28±0.37** 30.19±5.95* 3.48±0.14# 
5mMAc 17.5±1.2** 20.02±1.07# 4.8±0.4# 27.4±5.4* 3.8±0.2# 
, 
10 mM Ac 1,7.9±0.9** 20.91±1.16# S.6±1.1 ** 27.6±4.7* 3.9±0.3** 
30mMAc 18.5±0.3# 19.58±1.67# 7.0±0.9# 33.7±SJ* 4.1±OJ# 
I 
10 mM Glu 21.6±0.5 18.68±1.96# 11.8±1.t 42.6±9.0 3.0±0.2** 
I 
60 min 1mMAc 1,2.21±0.6# 17.79±1.21# 3.S6±0.24** 7.66±0.5S# 2.33±0.27 
I 
5mMAc ' \# 12.4±1.0 18.81±1.44# 11.S±4.0* 12.6±3.4* 2.2±0.2 
10mMAc 1O.0±1.2* 12.73±2.3S# 13.8±2.8# 4.9±1.2# 2.4±0.1 
30mMAc 9.S±0.9# 17. 13±1.07# 23.2±2.7# 16.0±S.4** 2.7±OJ 
10 mM Glu 19.0±1.5 19.33±0.64# 12.18±1.3** 43.0±4.S 2.4±0.1 
-_ ... _--------
--- ------- ----------
*p~0.05 vs control (30 min); **p~O.Ol vs control (30 min); #p~0.0005 vs control (30 min) 
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4.2 Aim 2: To determine the effect of oxygen availability during ischaemia on the 
beneficial effect of glucose and acetate 
4.2.1 Heart Rate (Table 4.4) 
Initial HR in 5 mM Ac and 10 mM Glu hearts were 323 beats/min and 262 beats/min 
respectively with no significant difference in the pre-ischaemic-anoxic HR between the 
two groups. However, after· 5 minutes of ischaemia-anoxia, the HR in both groups 
decreased significantly (p~0.001) to 90.S±90.S (5 mM Ac) and 114.0±25.4 beats/min. 
(10 mM Glu). They remained low throughout the ischaemic-anoxic period and 
recovered marginally during the reperfusion phase. After 25 minutes of reperfusion, the 
Ac hearts had recovered to 21.3±4.4 beats/min (individual values: */ lS/ */ */ 16/ 30 
beats/min.; * indicates that the hearts fibrillated so the HR could not be measured) while 
Glu treated hearts recovered to 22.0±7.9 beats/min (14/ */ 130/ */ */ * beats/min). 
There was however no significant difference in the HR between the groups at this point 
due to the large difference in SEM. 
4.2.2 Coronary Flow (Table 4.5) 
There was no significant difference in the pre-ischaemic-anoxic CF between the two 
groups. During the ischaemic-anoxic period the CF was regulated at 2 mlImin. The 
recovery of CF upon reperfusion·was -equally poor(p~O.OOl) in both the Ac and Glu 
treated hearts. By the end of the experiment, CF in the Ac perfused hearts had only 
recovered to 6.0±1.5 mlImin. with Glu recovering to 4.0±1.4 mlImin. 
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Table 4.4 Heart Rate (beats/min) at different stages during the experiment in 
# ischaemic-anoxic hearts. Ac = acetate, Glu = glucose. 
Time 5mMAc 10 mM Glu 
(min) 
Pre - 5 322.5±12.1 307.5±16.2 
ischaemic 15 287.5±17.1 276.7±30.9 
Phase 25 275.0±13.8 262.5±18.9 
Ischaemic- 35 90.8±90.8 114.0±25A 
anoxic 45 * 37.5±7.5 
Phase 55 * 53.0±26.1 
Reperfusion 65 23.5±7.6 46.0±37.0 
Phase 75 26.0±2A 18.O±O.O 
85 21.3±4A 22.0±7.9 
*HR could not be determined as there was no visible developed pressure or EeG 
recording after approximately 5 minutes of ischaemia-anoxia. 
Table 4.5 Coronary flow (mllmin) at different stages during the experiment in 
ischaemic-anoxic hearts. Ac = aC~,tate, Glu = glucose. 
Time 5mMAc 10 mM Glu 
(min) 
Pre- 5 17.2±OA 15.5±1.2 
ischaemic 15 16.7±O.7 14.5±1.3 
Phase, 
- -
25 ._.- 15.1:1;.0.5 - -- 13.9±O.7 
Ischaemic- 35 2.0±3A 1.9±O.1 
anoxic 45 2.0±3.1 2.O±O.O2 
Phase 55 2.0±2.1 2.O±O.O 
Reperfusion 65 5.0±1.1 2.3±O.8 
Phase 75 5.5±1.3 3.0±O.9 
85 6.0±1.5 4.0±1.4 
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4.2.3 Time to the onset of ischaemic contracture (TOle) (Figure 4.8) 
There was no significant difference in the TOIC between the Ac (63.0±6.01 s) and Glu 
(64.0±9.5 s) treated hearts. 
4.2.4 Percentage recovery of left ventricular developed pressure (LVDP) (Figure 
4.9) 
There was no significant difference in the percentage recovery of L VDP between the Ac 
(0.5±0.5) and Glu (2.0±2.0) treated hearts. One out of six hearts recovered in each 
group which accounts for the unusual SEM. 
4.2.5 Tissue ATP content (Table 4.6 and Figure 4.10) 
Prior to ischaemia-anoxia tissue ATP levels measured 22.2±0.5 umoVg d.w. By the 
onset ofIC it had declined (p~0.001) to 14.7±1.0 (Ac) and 13.9±0.8 umoVg d.w. (Glu) 
and continued to decrease throughout the ischaemic-anoxic period. There was no 
difference in ATP content between the two groups at the onset ofIC or after 30 minutes 
of ischaemia-anoxia. 
In comparison with the ischaemic groups, the ischaemic-anoxic hearts showed a sharper 
decline in tissue ATP content at the onset ofIC. By the end of the ischaemic period the 
.... - . - -~ ---. - -- -"- - - -
ATP levels in ischaemic-anoxic hearts were significantly lower than that of the ischaemic, 
particularly the Glu treated hearts. 
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4.2.6 Tissue CP content (Table 4.6 and Figure 4.11) 
Pre-ischaemic tissue CP levels measured 39.6 ± 0.4 umol/g d.w. During ischaemia-
anoxia tissue CP decreased (p~0.01) to 10.4±1.5 umol/g d.w. (Ac) and 11.6±0.9 umol/g 
d.w. (Glu) as measured at the onset one. There was no difference between the Ac and 
Glu hearts at this point. After 30 minutes of ischaemia-anoxia, CP levels in Ac hearts 
(1.3±0.7 umol/g d.w.) were significantly lower than in the Glu treated hearts. 
Furthermore, anoxia increased CP break down as shown by the lower CP levels in 
comparison with the groups subjected to ischaemia during the same period. 
4.2.7 Tissue Lactate content (Table 4.6 and Figure 4.12) 
The tissue lactate level prior to ischaemia was 1.5±0.4 umol/g d.w. An increase 
(p~0.001) was observed at the onset onc in both the Ac (l6.1±2.5 umol/g d.w.) and 
Glu (14.8±1.3 umol/g d.w.) hearts. The apparent slight reduction in lactate noted at the 
end of the ischaemic-anoxic period was not significant. There was also no significant 
difference in tissue lactate between the Ac and Glu hearts at both the onset onc and at 
the end of ischaemia-anoxia. The increase in tissue lactate content during this period was 
also greater in ischaemic-anoxic hearts than ischaemic groups. 
4.2.8 Tissue Glycogen content (Table 4.6 and Figure 4.13) 
Compared to the pre-ischaemic levels (62.4 ± 10.6 umol/g d.w.), tissue glycogen content 
had decreased significantly at the onset onc in both the Ac (30.6±3.3 umol/g d.w.) and 
Glu (l7.3±1.5 umol/g d.w.) perfused hearts. The glycogen levels had diminished even 
further by the end of the ischaemic-anoxic period (Ac 6.5±1.4 umol/g d.w.; Glu 6.7±1.8 
umol/g d.w.). There was however no differences in tissue glycogen content between the 
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two groups at the onset ofIe or after 30 minutes of ischaemia. While ischaemic 5 mM 
Ac treated hearts showed glycogen decreases similar to ischaemic-anoxic Glu and Ac 
perfused hearts, ischaemic Glu hearts lessened the fall in tissue glycogen content 
significantly. 
4.2.9 Tissue cAMP content (Table 4.6 and Figure 4.14) 
In comparison with tissue cAMP content prior to ischaemia-anoxia (2.3±0.1 nmoVg 
d.w.), tissue cAMP content increased (p~O.OOI) at the onset of Ie in the Ac (4.4±0.3 
nmoVg d.w.) and Glu (3.8±0.1 nmoVg d.w.) treated hearts. By the end of the ischaemic-
anoxic period, these levels had decreased significantly to 1.4±0.3 nmoVg d.w. (Ac) and 
2.3±0.3 nmoVg d.w. (Glu). However, there was no significant difference in tissue cAMP 
content between the two groups at the onset of Ie or after 30 minutes of ischaemia-
anOXia. 
Ischaemia-anoxia increased the tissue cAMP levels at the onset of Ie in Glu treated 
hearts in comparison with hearts subjected to ischaemia. In this respect, ischaemic-
anoxic glucose treated hearts performed just as poorly as those perfused with 5 mM Ac 
subjected to anoxia and or ischaemia. By the end of the ischaemic-anoxic period 
however, ischaemic-anoxic 5 mM Ac hearts had significantly lower cAMP levels than the 
_. - __ - - - __ "0 
other groups. 
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Table 4.6 Tissue ATP, CP'llactate, glycogen, and cAMP levels in ischaemic-anoxic hearts_determined prior to ischaemia (30 min), at the 
, 
onset ofischaemic contracture (OIC) and at the end ofthe ischaemic period (60 min). Ac = acetate; Glu = glucose 
i 
Substrate ATP CP Lactate Glycogen cAMP 
(umollgd.w.) (umollgd.w.) (umollg .w.) (umollgd.w.) (nmollgd.w.) 
30 min (control) 22.2±0.5 39.6±OA 1.5±OA 62A±10.6 2.3±0.1 
OIC 5mMAc 14.7±1.0** lOA±1.5* 16.1±2.5** 30.6±3.3* 4.4±0.3** 
10 mM Glu 13.9±0.8** 11.6±0.9* 14.8±1.3** 17.3±1.5** 3.8±0.1 ** 
60 min 5mMAc 7.2±0.6** 1.3±0.7** 14.8±7.8 6.5±1.4** lA±O.3 
10 mM Glu 9.3±1.9** 6.6±1.7** 14.6±3.7 6.7±1.8** 2.3±0.3 
*p~0.05 vs control (30 min); **p~O.OOI vs control (30 min) 
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4.3 Aim 3: To ascertain whether equi-carbon concentrations of glucose and 
acetate offer similar protection during subtotal ischaemia 
4.3.1 Heart Rate (Table 4.1; p. 52) 
77 
The pre-ischaemic HR in the two groups was similar, but after 5 minutes of ischaemia 
the HR had declined to 106±24.4 beats/min (Ac) and 135.0±21.2 beats/min (Glu). By 
the end of the ischaemic period the HR in Ac treated hearts had declined even more to 
60.0±12.8 beats/min while than the Glu perfused hearts had HR of 162.5±18.5 
beats/min.. However, after five minutes of reperfusion, the Ac HR recovered to 
170.0±52.1 beats/min which was not significantly different to that of Glu treated hearts 
at 235.0±6.3 beats/min. 
4.3.2 Coronary Flow (Table 4.2; p. 53) 
Variations in coronary flow followed a trend similar to that of the HR. Pre-ischaemic CF 
rates were similar, while ischaemic rates were regulated at 2mVmin. Recovery of 
coronary flow was initially delayed in Ac hearts (9.6±0.7 mVmin) in comparison (p~0.01) 
with that ofGlu (13.2±0.8) which may indicate some degree of stunning in the Ac hearts. 
There were no significant differences in CF after 90 minutes of perfusion. 
4.3.3 Time to Onset oflschaemic Contracture (TOIC) (Table 4.7) 
Glucose abolished IC while Ac accelerated the onset to IC (65 ± 9.8 s). 
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4.3.4 Percentage recovery of Left Ventricular Developed Pressure (LVDP) (Table 
4.7) 
With 30 mM Ac as substrate, the recovery of LVDP was 23.8±2.8 % whereas hearts 
perfused with 10 mM glucose showed improved recoveries of79.8±4.1 % (p~0.0005). 
Table 4.7 Time to the onset of ischaemic contracture (TOIC) and the percentage 
recovery of left ventricular developed pressure (L VDP) in hearts perfused with 
either acetate (Ac) or glucose (Glu) 
30 mM Ac 10 mM Glu 
TOIC (seconds) 65.0 ± 9.8 None 
% Recovery LVDP 23.8 ± 2.8 79.8 ± 4.1 
4.3.5 Tissue ATP content (Table 4.3 and Figure 4.15) 
Tissue ATP levels declined during ischaemia in the Ac hearts only. The difference in 
ATP between Glu and Ac was already noticeable at the onset of IC (p~0.0005) while 
levels in Glu hearts (19.0±1.5 umol/g d.w.) was double that of Ac (9.5±0.9 umol/g d.w.) 
perfused hearts after 30 minutes of ischaemia (p~0.0005). 
4.3.6 Tissue CP content (Table 4.3 and Figure 4.16) 
Creatine phosphate also decreased during ischaemia, but there were no significant 
differences between the Ac and Glu hearts. 
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4.3.7 Tissue Lactate content (Table 4.3 and Figure 4.17) 
Ac treated hearts showed more of an increase in lactate content than glucose hearts at 
the onset ofIC (p~O.05). By the end of the ischaemic period, lactate levels in Ac hearts 
(23.2±2.7 umol/g d.w.) exceeded that ofGlu hearts (12.18±1.3 umol/g d.w. )(P~O.005). 
4.3.8 Tissue Glycogen content (Table 4.3 and Figure 4.28) 
Glu had a glycogen sparing effect while glycogen mobilisation was increased in Ac 
hearts. The decrease in tissue glycogen at the onset of IC was similar in both groups. 
However Glu abated a further reduction in glycogen (43.0±4.5 umol/g d.w.) while Ac 
had the opposite effects (16.0±5.4 umol/g d.w.) (p~O.005). 
4.3.9 Tissue cAMP content (Table 4.3 and Figure 4.19) 
The increase in cAMP observed at the onset of IC was greater in Ac (4.1±O.3 nmol/g 
d.w.) hearts compared to Glu (3.0±O.2 nmol/g d.w.) treated hearts (p~O.05). Tissue 
cAMP levels had declined similarly in both groups by the end ofthe ischaemic period. 
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Chapter 5 
DISCUSSION 
5.1 Acetate dose response 
The rate of utilisation of any substrate depends on, amongst others, the, substrate 
concentration and oxygen delivery to the myocardium (Neely et aI., 1972). Previous 
studies involving acetate as a substrate utilised concentrations varying from 3,6 to 10 
mM (Williamson, 1964; Bricknell and Opie, 1978; Owen and Opie, 1990). This study 
implies that the optimum concentration for the provision of acetate to the isolated 
perfused rat heart during subtotal ischaemia appears to be 5 mM and 10 mM when the 
ischaemic coronary flow was regulated at 2 mlImin. These concentrations had fewer 
deleterious effects indicated by improved reperfusion recovery and delayed TOle. 
The biochemical data showed no significant differences amongst the groups. The TOIC 
and percentage recovery ofLVDP were therefore the only criteria which gave conclusive 
evidence as to the benefit or harm of a particular acetate concentration. 
5.1.1 Ischaemic contracture and percentage recovery of LVDP 
In agreement with Ventura-Clapier and Veksler (1994), the systolic pressure decreased 
visibly within seconds of the onset of ischaemia. lschaemic contracture developed in 
under four minutes in all acetate perfused hearts. The difference in TOIC between the 5 
mM and 10 mM acetate treated hearts was insignificant, implying that this may be the 
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optimal range of acetate concentration to use as an ischaemic substrate. Furthermore, 
hearts with the earliest TOIC displayed the poorest recovery of LVDP. These results 
support the findings of Apstein et ai. (1983) who found low reperfusion recoveries 
following increased diastolic pressure during the ischaemic phase in isolated perfused 
rabbit hearts. Since acetate was the sole exogenous substrate, recoveries of 53.5±2. 74 
% (5 mM Ac) and 48.3±3.9 % (10 mM Ac), despite being low, indicate residual Krebs 
Cycle activity in maintaining reperfusion function. 
Another factor which may have affected the TOIC is the Na+ concentration of the 
ischaemic perfusate. The acetate was derived from sodium acetate, therefore the 
incremental increases in the acetate concentration of the ischaemic perfusate was possibly 
accompanied by similar increases in the Na+ concentration. 
Increased intracellular Na+ levels may reduce the Na+ electrochemical gradient across 
the sarcolemma and lead to reversal of the Na+ /Ca+ exchanger. Na+ extrusion from the 
cell is thus coupled to Ca++ ingress resulting in a rise in cytosolic Ca++ levels (Sedlis et aI., 
1983). Cytosolic Ca++ accumulation has been implicated as a cause ofIC (Bricknell and 
Opie, 1978; Kihara et aI., 1989; Ventura-Clapier and Veksler, 1994). Therefore, if the 
increases in the acetate concentration is related to increased Na+ levels in the perfusate, 
hearts perfused with higher concentrations of acetate should hypothetically develop IC 
sooner. Although the present study showed that hearts perfused with a high 
concentration (30 roM) of acetate had the shortest TOIC, their was no trend showing a 
relationship between increased acetate concentrations and a shorter TOIC. Additional 
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deleterious effects of Na+ accumulation include increased osmolarity, disruption of the 
RMP and the generation of abnormal action potentials. 
We cannot however confirm any changes in the Na+ levels since we did not measure the 
electrolyte concentrations ofthe perfusate. 
5.1.2 Interaction of biochemical and functional parameters 
a) High Energy Phosphates 
Our data indicate a significant decrease in tissue ATP at the onset of IC in all acetate 
treated hearts. However, in support of Owen et aI. (1990), the current study showed 
that the initial breakdown of CP was greater than that of ATP. This suggests that the 
decrease in tissue ATP during ischaemia was buffered, but could not be prevented by CP 
(Spiekermann, 1990). 
-Factors that may have contributed to the decline in ATP during ischaemia include those 
which decrease ATP production and increase ATP utilization. ATP production is limited 
by, arriongst others, reduced oxygen availibility and as well as increased lactate levels 
(Rovetto et aI., 1973; Neely et aI., 1975). Lactate not only inhibits glycolysis, but also 
leads t'o acyl CoA-accumulatIon. 
__ _ 4 
This in turn prevents transport of ADP from the 
cytoplasm to the mitochondrion. As a result, there may be insufficient ADP in the 
mitochondrion for ATP synthesis (Rovetto et aI., 1975). Enhanced ATP utilization may 
be stimulated by increased activity of ATP dependent pumps. As previously mentioned, 
incremental increases in the acetate concentration could have been accompanied by 
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similar increases in the Na+ content of the ischaemic perfusate. The resultant rise in the 
cytosolic Na+ levels would have induced greater activity of the ATP dependent Na+ /K+ 
pumps thereby contributing to the decline in ATP levels during ischaemia. 
Hypothetically, IC is a consequence of reduced ATP levels and or raised cytosolic Ca ++ 
levels (Koretsune and Marban, 1990; Owen et aI., 1990; Ventura- Clapier and Veksler, 
1994). In the current study however, tissue ATP content in the various groups did not 
correlate well with the TOle. Therefore, in keeping with the findings of Owen et ai. 
(1990), the present study could not find a clear relationship between tissue ATP levels 
and the onset one. In this respect, Bricknell and Opie (1978) and Vanoverschelde et ai. 
(1994) found that the actual rate of ATP synthesis, specifically glycolytic ATP (Owen et 
aI., 1990) may be more important than gross tissue ATP content. Furthermore, in 
support of Neely and Grotyohann (1984), this study could not show a correlation 
between tissue ATP and recovery of function during reperfusion either. 
Alternatively, ATP availability may influence the incidence one. Increased provision of 
acetate may have resulted in elevated acyl CoA production. This in tum inhibits adenine 
nucleotide translocase which is responsible for the transfer of ATP from the 
mitochondrion to the cytoplasm (Rovetto et aI., 1975). Therefore the amount of ATP 
available in the cytoplasm may have been reduced. If diminished ATP availability 
predisposes IC, the incremental increase in acetate concentrations should correspond 
with a decrease in TOle. Our data however does not reflect this trend. 
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b) Lactate 
The raised tissue lactate content during ischaemia corresponded with the increase in 
acetate concentration. Differences in tissue lactate between ImM and 30 mM acetate 
hearts could be due to either the degree of glycogenolysis -or inhibition of carbohydrate 
flux through the Krebs Cycle. The latter may be the result of increased acetyl CoA 
formation which inhibits PDH and results in a greater conversion of pyruvate to lactate 
(Neely and Morgan, 1974; Ferrari and Opie, 1992). There were no significant 
differences in tissue glycogen content between the groups, therefore implying that 1 mM 
acetate exercised less inhibition on carbohydrate flux and resulted in lower tissue lactate 
content. Although PDH activity and tissue acetyl CoA content was not measured, our 
data may suggest that 30 mM acetate was associated with increased lactate levels, 
possibly due to PDH inhibition. 
Accumulation of tissue lactate is also believed to be detrimental to ventricular functional 
recovery (Neely and Grotyohann, 1984) by inhibiting glycolysis (Williamson et al., 
1976), and leading to intracellular acidosis (Brachfeld, 1969). In contrast, the current 
study found that the 1 mM acetate group, with the lowest lactate content, was associated 
with the poorest recovery. The opposing findings may be due to differences in 
experimental design. The current study used a low flow ischaemic model whereas Neely 
and Grotyohann-(l984) used a no-flow ischaemic-model where lactate accumulation was 
a result of reduced metabolite washout. 
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c) Glycogen 
Tissue glycogen content decreased similarly in all acetate treated hearts. According to 
King et al. (1995), glycogen is capable of delaying the onset of IC, yet in the current 
study, IC developed within 4 minutes in all groups. Furthermore, 5 mM and 10 mM 
acetate delayed the TOIC significantly longer than 1 mM and 30 mM acetate despite the 
fact that all acetate treated hearts had similar tissue glycogen levels at the onset of Ie. 
Instead our data support the proposal by Owen et al. (1996) that glycolytic ATP 
synthesis from glucose is needed for protection against IC. 
The decreased ischaemic glycogen content may have contributed to the poor recovery of 
L VDP in the acetate perfused hearts. Pre-ischaemic perfusion with 5 mM acetate is 
known to reduce the tissue glycogen content, provoking speedier glycogen depletion 
during ischaemia. According to Gros~ et al. (1996) glycogen depletion would lead to 
reduced glycolytic activity and subsequent accumulation of protons. Upon reperfusion, 
this proton accumulation increases Na+1IY exchange which provokes poor recoveries. 
However, no correlation between the glycogen content and percentage recovery of 
L VDP amongst all groups could be found in the present study. 
d) cAMP 
Elevated cAMP levels were observed at the onset ofIC, suggesting that it plays a role in 
ischaemic contracture. Mechanisms for the increase in cAMP could have been due to 
either metabolic activation of adenylyl cyclase or inhibition of phosphodiesterase 
(Podzuweit et al., 1996). The decrease in cAMP levels observed at the end of ischaemia 
may have been the result of downgrading of the J3-receptors (Muller et al., 1987). 
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Cyclic AMP, together with adenosine, inhibits fatty acid metabolism in oxygen deficient 
hearts (Neely and Morgan, 1974). This may lead to an ATP shortage which contributes 
to the development ofIC (Koretsune and Marban, 1990; Owen et aI., 1990; Opie, 1990). 
Alternatively, cAMP could be more closely associated to the occurrence of IC by 
increasing intracellular Ca++ levels (Podzuweit et aI., 1976; Ventura-Clapier and Veksler, 
1994) through phosphorylation of the Ca ++ channels and subsequent Ca ++ stimulated Ca ++ 
release. This cannot however be confirmed as the Ca++ levels was not measured in the 
current study. 
5.2 Effect of oxygen availability on beneficial effect of glucose and acetate 
The current study showed that, in the presence of oxygen, 10 rnM glucose protected the 
ischaemic heart by abolishing IC and improving recovery of function upon reperfusion. 
In contrast, 5 rnM Ac accelerated the TOIC and yielded weaker reperfusion recoveries. 
However, in the absence of oxygen during ischaemia, both glucose and acetate treated 
hearts developed IC soon after initiation of ischaemia and displayed equally poor 
reperfusion recoveries. These results imply that the protective effects of glucose is 
oxygen dependent and the Krebs Cycle may playa role in these effects. 
5.2.1 Interaction between ischaemic contracture and biochemical parameters 
Ischaemic contracture, supposedly a result of deficient ATP and or Ca ++ overload 
(Bricknell and Opie, 1978; Grossman and Barry, 1980; Korestsune and marban, 1990; 
Owen et aI., 1990), developed soon after the beginning of ischaemia in both the 
ischaemic-anoxic glucose and acetate treated hearts. The early development of IC in 
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ischaemic-anoxic acetate perfused hearts was expected since acetate metabolism, 
involving ~-oxidation and oxidative phosphorylation, is oxygen dependent. Acetate 
treated hearts would then have had to rely solely on glycogen as a sOurce for ATP 
synthesis. The decrease in tissue glycogen content during ischaemia supports this theory. 
However, Owen et ai. (1990) speculated that ATP production from glycogen is less 
capable than glycolysis from glucose in maintaining Ca++ homeostasis across the 
sarcolemma, assuming that inadequate Ca ++ homeostasis is linked to Ie. And since the 
TOIC Was accelerated in acetate treated hearts, the current study found, contrary to 
King et ai. (1995), that glycogen was ineffective in delaying the onset of IC during 
ischaemia-anoxia. 
Assuming that glycolytic ATP production from glucose maintains Ca++ homeostasis 
(Owen et aI., 1990) and elevated cytosolic Ca ++ causes IC (Grossman and Barry, 1980; 
Ventura-Clapier and Veksler, 1994), ATP synthesis via anaerobic glycolysis should 
hypothetically prevent IC. However, the current study showed that TOIC was 
accelerated in glucose perfused ischaemic-anoxic hearts. A possible explanation for the 
development of IC in these hearts could be that anaerobic glycolysis may only playa 
minor role in preventing IC. The beneficial effects of glucose may either be directly 
dependant on oxygen through oxidative phosphorylation, or indirectly through the 
incorporation- of pyruvate into the Krebs Cycle. Anoxia inhibits pyruvate flux through 
the Krebs Cycle which is then converted to lactate (Neely and Morgan, 1974). When 
lactate accumulates, glycolysis is inhibited (Neely et aI., 1975; Williamson et aI., 1976). 
The resultant ATP shortage would hinder Ca ++ homeostasis and predispose intracellular 
Ca ++ overload accompanied by IC (Kusuoka and Marban, 1994). This would account for 
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lower ATP levels and development ofIC as noted in both acetate and glucose perfused 
anoxic hearts. Thus, the protection conferred by glucose, in the presence of O2, against 
the development of IC may be attributed to either ATP production via oxidative 
processes or by reducing lactate accumulation which inhibits glycolytic flux. 
Similar increases in tissue cAMP in the glucose and acetate ischaemic-anoxic hearts 
corresponded with the onset of Ie. However, cAMP levels in Glu hearts subjected to 
ischaemia-anoxia were significantly lower compared to hearts perfused with a buffer 
aerated· with -95%02 ; 5%C02• Therefore, if elevated cAMP levels increase cytosolic 
Ca++ which in turn causes IC (Grossman and Barry, 1980; Ventura-Clapier, 1994), IC 
should have developed in glucose hearts perfused with oxygenated buffer during 
ischaemia. Instead, glucose abolished IC in the presence of O2 while TOIC was 
accelerated when O2 was omitted from the perfusate despite significant differences in 
cAMP content. In accordance with Koretsune and Marban (1990) our results suggest 
that an ATP deficit correlates much better with the occurrence of IC. Alternatively, 
cAMP fluctuations may not necessarily determine the occurrence of IC. According to 
Owen and Opie (1978) hypoxic damage or ATP depletion would result in the ingress of 
Ca ++ and have the same effects as cAMP accumulation. 
5.2.2 Percentage Recovery of Left Ventricular Developed Pressure 
Ischaemia-anoxia impaired the recovery of L VDP similarly in both the glucose and 
acetate treated hearts. These poor recoveries may be attributed to various factors. Neely 
et al. (1975) suggested that inhibition of O2 dependent energy generating pathways 
increased lactate induced glycolytic inhibition with subsequent ATP shortage. According 
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to Spiekermann (1990), this lack of energy may be the mam cause of functional 
impairment. In support of Neely et ai. (1975), the present study showed lower tissue 
ATP levels corresponding with higher tissue lactate levels in all ischaemic-anoxic hearts 
compared to ischaemic hearts. This increased ischaemic lactate levels may have 
contributed to the low recovery of function during reperfusion (Neely and Grotyohann, 
1984). In keeping with the findings of King et ai. (1995) the current study also showed 
poor recovery of reperfusion coronary flow in all ischaemic-anoxic hearts. This may 
have been due to mechanical compression of coronary arteries when Ie developed 
(Humphrey et aI., 1980). As a result there may have been insufficient washout of 
metabolic products which contributed to tissue damage (Neely et aI., 1973) and poor 
reperfusion recovery. 
According to Neely and Grotyohann (1984) glycogen breakdown also affects the extent 
of reperfusion recovery by contributing to tissue damage through metabolite 
accumulation. The present study showed that ischaemia-anoxia stimulated 
glycogenolysis, as reflected by similar decreases in ischaemic tissue glycogen content in 
all groups (Neely and Morgan, 1974). However, Neely and Grotyohann (1984) used a 
total, global ischaemic model whereas a low-flow (2ml1min.) model was used in the 
current study. Therefore the detrimental effects of glycogen breakdown in their study 
may be attributed to . reduced washout of metabolic products which is not applicable to 
the current study. 
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5.3 Egui-carbon concentrations of glucose and acetate as ischaemic substrates 
Despite the presence of residual oxygen, 30 mM acetate could not offer protection 
equivalent to that of 10 mM glucose during low flow ischaemia. These results support 
Bricknell and Opie (1978) who also found that glucose abolished Ie while acetate 
accelerated the onset of IC. In addition, acetate worsened L VDP which, assuming that 
acetate is a fatty acid, is in keeping with Coleman et ai. (1989) who found that fatty acids 
have negative effects on developed pressure. 
It is accepted that glucose may protect the ischaemic myocardium (Opie, 1970; Owen et 
aI., 1990). Part of glucose protection may be due to glucose oxidation, specifically 
oxidative phosphorylation and the Krebs Cycle (Lopaschuk, 1998). In this respect, an 
equi-carbon concentration of acetate (30 mM), which is incorporated into the Krebs 
Cycle as acetyl-CoA, may offer protection similar t6 glucose (10 tnM). 
According to Bricknell et aJ. (1981) glycolytic ATP is needed for protection against Ie. 
This implies that acetate treated hearts would have had to rely on glycogenolysis to 
prevent Ie. Since IC developed in acetate treated hearts but not in glucose perfused 
hearts, these results support the proposal that ATP production from glycogen may be 
less effective than that from glucose in preventing IC (Owen et aI., 1990). A similar 
trend was found by Oliver and Opie (1994) who proposed that Glu protected the 
ischaemic myocardium, possibly through better control of Ca ++ homeostasis, while 
acetate had the opposite effects, assuming that IC is linked to inadequate Ca ++ 
homeostasis. 
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5.3.1 Tissue ATP content 
These results show that the decrease in tissue ATP during ischaemia was buffered by the 
provision of glucose but not by acetate. The onset of IC in acetate hearts was followed 
by a rapid decrease in tissue ATP content as found by Vanoverschelde et al. (1994) and 
Cross et al. (1996). This may have been due to inhibition of flux through the Krebs 
Cycle by enhanced production of acetyl CoA (Braunwald, 1992), which accompanies 
increased provision of acetate. Not only would this hinder ATP production but also 
increase conversion of pyruvate to lactate in acetate treated hearts (Neely and Morgan, 
1974). Acetate, as a fatty acid, would also inhibit glycolysis (Shipp et al., 1961), thus 
further promoting an ATP deficiency. The decline in ATP content in acetate treated 
hearts may also be attributed to increased activity of the ATP dependent sodium-
potassium pump. 
5.3.2 Tissue Lactate content 
Tissue lactate levels at the onset of IC were higher in glucose hearts, possibly due to 
accelerated glycolytic flux. However, it had not increased further by the end of 
ischaemia. This may indicate maintenance of Krebs Cycle activity, therefore preventing 
lactate accumulation. In contrast, lactate levels in acetate hearts were elevated at the end 
of the ischaemic period. This may have been due to increased formation of acetyl-CoA 
which inhibits PDH, thereby encouraging lactate formation (Neely and Morgan, 1974; 
Braunwald, 1992). 
Increased tissue lactate levels may have contributed'to the early development of IC and 
poor reperfusion recovery in acetate treated hearts. Ischaemic contracture is supposedly 
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a consequence of reduced ATP availability (Koretsune and Marban, 1990; Owen et aI., 
1990). Ischaemic lactate production has been said to inhibit glycolysis (Neely et aI., 
1975) and thus contribute indirectly to an ATP deficiency. This ATP deficiency may 
then encourage the development of IC by preventing restoration of resting Ca ++ levels 
and inhibiting dissociation of the actin-myosin cross-bridges (Grossman and Barry, 
1980). In addition, Ca++ uptake into the SR is controlled by an ATP-dependent pump 
which is maintained by glycolytic ATP (Opie, 1987). Therefore, when glycolysis is 
inhibited, Ca++ may accumulate and lead to the development of IC. Furthermore, lactate 
is believed to contribute to intracellular acidosis (Rovetto et aI., 1973), which in turn 
inhibits glycolysis (Williamson et aI., 1976) and thus aids the development ofIC (Allen, 
1988). However, this argument is questionable since Dennis et aI. (1991) has shown that 
lactate is an unlikely source of protons. High ischaemic tissue lactate has also been 
associated with poor reperfusion ventricular function recovery in a total global ischaemic 
model (Neely and Grotyohann, 1984). This may partially account for poorer reperfusion 
recoveries in Ac treated hearts compared to Glu hearts, a trend which was also found by 
Coleman et aI. (1989). 
5.3.3 Tissue cAMP content 
Since IC was not observed in the glucose hearts, higher cAMP levels at the onset ofIC 
in acetate hearts may implicate its involvement in the generation of IC. Elevated cAMP 
reportedly increased intracellular Ca++ (Podzuweit et al., 1976) which may cause IC 
(Ventura-Clapier and Veksler, 1994). High cAMP levels may also inhibit fatty acid 
metabolism (Neely and Morgan, 1974) which necessitates increased glycogen utilisation 
(Neely et al., 1970). A similar trend was found in this study where lower tissue glycogen 
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content was associated with raised cAMP levels at the onset ofIC. The reduced tissue 
glycogen content may be due to increased phosphorylation of phosphorylase b to a by 
cAMP, resulting in the breakdown of glycogen to glucose-I-phosphate (Neely and 
Morgan, 1974). 
5.3.4 Tissue Glycogen content 
Glycogen utilisation increased during ischaemia in hearts perfused with acetate. Neelyet 
aL (1970) found similar results in hearts perfused with fatty acids, while Cross et aL 
(1996) observed that provision of glucose throughout ischaemia depleted glycogen 
minimally. Similarly, the present study showed that provision of exogenous glucose 
buffered a decrease in tissue glycogen. Neely and Grotyohann (1984) found that 
anaerobic glycolysis from glycogen leads to intracellular accumulation of lactate and 
protons in the total global ischaemic modeL The resultant acidosis could increase 
intracellular Ca++ and aid the development ofIC (Allen, 1988). This would explain why 
glycogen break down was higher in acetate hearts which developed IC as opposed to 
glucose treated hearts where there was no incidence of IC (Owen et aL, 1990). 
However, we cannot confirm that glycogenolysis predisposed acidosis or increased 
intracellular Ca ++. 
It is evident that 30 mM acetate could not offer protection equivalent to that of 10 mM 
glucose during low flow ischaemia. Possible reasons could be that glycolytic ATP is 
chiefly responsible for the protection conferred by glucose. ATP derived from oxidative 
phosphorylation and the Krebs Cycle may only playa minor role in this respect. Acetate 
perfused hearts would, as expected, perform poorly since it is believed that glycolytic 
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ATP from glucose is more effective than that from glycogen in protecting the ischaemic 
heart (Owen et aI., 1990). Alternatively, insufficient oxygen supply to allow functioning 
of oxidative phosphorylation and prevent conversion of pyruvate to lactate may have 
contributed to the poor results. This would leave glycolysis as the main source of ATP. 
Acetate perfused hearts would then have had to rely on glycogen as a source of energy. 
This may explain the lower ATP and glycogen levels noted in acetate treated hearts. 
The acetate which was used as a substrate in the ischaemic perfusate was derived from 
sodium acetate. The solution used to perfuse the acetate treated hearts would then have 
had a higher sodium concentration than the glucose treated hearts. Since increased 
sodium levels have detrimental effects such as increased osmolarity, cell swelling, 
disruption of the RMP, generation of abnormal action potentials, increased ATP 
utilization and raised cytosolic calcium levels, it may account for the poor performance 
of the acetate treated hearts. 
Another plausible explanation is that despite providing the hearts with equi-carbon 
concentrations of glucose and acetate, the ATP production from these substrates is quite 
different. Theoretically, oxidation of 10 mM glucose would yield more ATP than 30 
mM acetate. Acetate is a two carbon substrate which does not undergo B-oxidation but 
provides acetyl-CoA directly to the Krebs Cycle. However, B-oxidation appears to be 
an important source ofNADH and F ADH2 which is oxidised to form ATP via oxidative 
phosphorylation. Perhaps the metabolism of a longer chain fatty acid, involving B-
oxidation, may yield more favourable results. 
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Since acetate does not contribute to anaplerotic pathways, a reduced oxaloacetate level 
may have also contributed to the dismal performance of acetate treated hearts. Lower 
oxaloacetate concentrations would prevent the incorporation of acetyl CoA into the 
Krebs Cycle and as a result, limit ATP production. Glucose on the other hand, 
contributes to the anaplerotic pathways through the conversion of pyruvate to 
oxaloacetate and malate. Acetate treated hearts would have had to rely on glycogen as a 
source for pyruvate production. The synthesis of oxaloacetate from pyruvate is ATP 
dependent, therefore the low ATP levels noted in acetate treated hearts would have 
inhibited this pathway and ultimately leading to a further decrease in ATP levels. We 
cannot however be sure that the oxaloacetate content was the limiting factor as we did 
not measure its concentration. 
Our aim was to provide the hearts with equi-carbon concentrations of acetate and 
glucose in the form of30 mM acetate and 10 mM glucose. However, 2-C atoms of the 
glucose 6-C are exhaled as CO2 when pyruvate is converted to acetyl CoA. Only 4-C 
atoms are therefore burned up during the Krebs Cycle, so it may be argued that 20 mM 
acetate is actually equi-carbon to 10 mM glucose. Since the acetate dose response 
showed that 5 mM and 10 mM acetate were equally protective during ischaemia, perhaps 
20 mM acetate would have exerted beneficial effects as well. 
Finally, the high concentration of acetate may have simply been too toxic. Mechanisms 
underlying fatty acid toxicity include inhibition of glycolysis, preventing pyruvate flux 
through the Krebs Cycle and accelerated enzyme release (Wilkinson and Robinson, 
1974). In addition, fatty acids promote Ca++ overload via inhibition of the SR Ca++ 
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pump, the sarcolemmal Na+/Ca++ exchanger and Na+-K+ pump, as well as activation of 
the Ca++ channels (Oliver & Opie, 1994). FFA are also directly arrhythmogenic in the 
isolated rat heart (Makiguchi et aI., 1991). Therefore the deleterious effects of 30 mM 
acetate outweighed any beneficial effects of an exogenous substrate during subtotal 
ischaemia. 
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Chapter 6 
CONCLUSION 
The optimal acetate concentration which best protected the isolated rat heart against the 
consequences of low flow ischaemia was both 5 mM and 10 mM acetate. These 
concentrations yielded improved, yet similar, function upon reperfusion and delayed the 
onset of IC equally. Hearts perfused with ImM and 30 mM acetate consistently 
displayed poor recoveries and accelerated TOIC. 
This study showed that the protection offered by glucose to the ischaemic myocardium is 
oxygen dependent. Therefore, the beneficial effects of glucose may be partly attributed 
to the maintenance of Krebs Cycle activity and oxidative phosphorylation. However, the 
deleterious effects of ischaemia-anoxia on glycolysis may have also contributed to the 
poor performance of glucose treated anoxic hearts. 
Equi-carbon concentrations of acetate and glucose could not offer similar protection 
during subtotal ischaemia. Acetate (30 mM) treated hearts accelerated the time to the 
onset of IC and worsened the percentage recovery of LVDP while glucose (10 mM) 
abolished IC and improved reperfusion recovery. Acetate hearts displayed increased 
tissue cAMP and lactate levels accompanied by lower ATP and glycogen content during 
ischaemia. Thus 10 mM glucose protected maximally against the consequences of 
ischaemia in the presence of oxygen. This may argue for additional protection via 
oxidative phosphorylation and the Krebs Cycle. 
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Reservations to this study 
1. In order to obtain a more comprehensive image of metabolic changes during 
ischaemia, additional tissue samples should be taken at shorter intervals for 
biochemical analysis. 
2. Measuring biochemical changes during the reperfusion period could help to 
substantiate L VDP data. 
3. The oxaloacetate concentration is a crucial factor in determining the incorporation of 
acetate into the Krebs cycle. It would therefore be advisable to measure tissue 
oxaloacetate content to determine acetate flux through the Krebs Cycle. 
4. The acetate, which was used as a substrate in the ischaemic perfusate, was derived 
from sodium acetate. Solutions containing acetate would then have had higher 
sodium levels than those without acetate. Similarly, incremental increases in the 
acetate concentration would also have resulted in increased sodium levels. To 
maintain a balance in the sodium content of the perfusion solutions, sodium should 
be omitted from any buffers to which sodium acetate is to be added. Measuring the 
electrolyte concentations of all perfusion solutions would also ensure that the 
substrate is the only variable component in the solution. 
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